JP3585238B2 - 真核細胞における部位特異的突然変異誘発のための化合物および方法 - Google Patents

真核細胞における部位特異的突然変異誘発のための化合物および方法 Download PDF

Info

Publication number
JP3585238B2
JP3585238B2 JP51636795A JP51636795A JP3585238B2 JP 3585238 B2 JP3585238 B2 JP 3585238B2 JP 51636795 A JP51636795 A JP 51636795A JP 51636795 A JP51636795 A JP 51636795A JP 3585238 B2 JP3585238 B2 JP 3585238B2
Authority
JP
Japan
Prior art keywords
nucleic acid
region
chimeric
regions
strand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP51636795A
Other languages
English (en)
Other versions
JPH09506511A (ja
Inventor
ビー． ミーク，エリック
Original Assignee
トーマス ジェファーソン ユニバーシティー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by トーマス ジェファーソン ユニバーシティー filed Critical トーマス ジェファーソン ユニバーシティー
Publication of JPH09506511A publication Critical patent/JPH09506511A/ja
Application granted granted Critical
Publication of JP3585238B2 publication Critical patent/JP3585238B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Environmental Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Description

1. 発明の分野
本発明は、分子遺伝学の分野に関するものである。特に、本発明は、生存している培養真核細胞に特定の遺伝的変異を導入するための核酸化合物ならびにその使用方法に関する。より詳細には、本発明は、二本鎖核酸の１本の鎖の一部が2'−Ｏまたは2'−OMeリボースを含むヌクレオチドからなり、残りの部分がデオキシリボースヌクレオチドからなる、実質的にワトソン・クリック型塩基対を形成した二本鎖核酸に関する。
2.発明の背景
2.1. キメラおよび／またはハイブリッド二本鎖核酸
本発明の分野は核酸に関するものである。核酸はヘテロポリマー、すなわち、配向されたホスホジエステル結合またはその誘導体によってポリマーへと連結されている、同一でないサブユニットのポリマーである。二本鎖核酸とは、ウラシルまたはチミンに対してはアデニン、シトシンに対してはグアニンという塩基対の法則に従って、二本鎖の第一鎖の各塩基が二本鎖の第二鎖の塩基に対応している核酸のことである。こうした対応（correspondence）を有する逆平行二本鎖はワトソン・クリック型対合（Watson−Crick pairing）をしていると言われる。二本鎖核酸には主に２つのタイプがあり、リボ核酸とデオキシリボ核酸である。それぞれのリボヌクレオチドには同様のデオキシリボヌクレオチドがあり、例えば、アデノシンとデオキシアデノシン、シチジンとデオキシシチジン、グアノシンとデオキシグアノシン、ウリジンとチミジンである。この分野において、リボヌクレオチドとデオキシリボヌクレオチドの両方が同一の鎖に存在している核酸は混合またはキメラ（以後「キメラ」と言う）核酸と称される。デオキシリボヌクレオチドとリボヌクレオチドが互いに対応している二本鎖核酸はハイブリッド二本鎖と呼ばれる。２本の鎖がそれらの塩基の一部において二本鎖核酸の領域を形成している場合、生ずる分子はヘテロ二本鎖と称される。
たいていの場合、二本鎖核酸の２本の鎖は共有結合しておらず、ワトソン・クリック型対合によってのみ結びついている。しかしながら、二本鎖の２本の鎖をオリゴヌクレオチドにより連結させて一本鎖ポリマーを形成することができる。リンキングオリゴヌクレオチドはワトソン・クリック型塩基対を形成しない。第一鎖と第二鎖が一本鎖ポリマーの一部であるヘテロ二本鎖は「ヘアピン二本鎖」または「ステム・ループ（stem and loop）」構造と呼ばれる。以後、前者の用語を用いることにする。
ここで用いるキメリズム（chimerism）は核酸ポリマーの特性であり、そしてハイブリディズム（hybridism）は二本鎖の特性である。例えば、mRNAとその鋳型はどちらもキメラではないがハイブリッド二本鎖を形成し、一方、例えば、キメラオクタヌクレオチド5'd（TTTT）−ｒ（CCCC）3'および5'r（GGGG）−ｄ（AAAA）3'は互いとワトソン・クリック型二本鎖を形成するであろうが、得られる二本鎖はハイブリッド二本鎖ではない。ハイブリッド二本鎖ではない二本鎖核酸を以後「ホモ二本鎖」と呼ぶことにする。特にことわらないかぎり、ホモ二本鎖核酸はデオキシヌクレオチド含有二本鎖のことである。なお、当業者はワトソン・クリック型二本鎖の形成を「ハイブリダイゼーション（ハイブリッド形成）」と呼んでいるが、その場合でさえハイブリッド二本鎖核酸は存在しないことに注意されたい。
Ｘ線回折および二次元NMRによるキメラおよび／またはハイブリッド二本鎖核酸の構造の研究に関心のある人達は、彼らの研究に使用するためのキメラ核酸およびハイブリッド二本鎖核酸を合成してきた。例えば、Salazar,M.ら,1994,J.Mol.Biol.241:440−55およびEgli,M.ら,1993,Biochemistry 32:3221−37（r3d7・d10型のキメラハイブリッド二本鎖）;Ban,C.ら,1994,J.Mol.Biol.236;275−85（d5r1d4型の自己相補的キメラハイブリッド二本鎖）;Chou,S.H.,1991,Biochemistry 30:5248−57（d4r4d4型の自己相補および非自己相補キメラハイブリッド二本鎖）を参照のこと。これらの二本鎖核酸の相補鎖は互いに共有結合で結びついているのではなく、ワトソン・クリック型対合によってのみ結びついていた。
キメラ核酸を合成した第二グループの科学者達は、リボザイム、すなわち自己開裂性であるかまたは他のRNAを開裂するRNA分子、の研究および使用に関心のある人達であった。Perreault,J.P.ら,1990,Nature 344:565;Taylor,N.R.ら,1992,Nucleic Acids Research 20:4559−65;Shimaya T.,1993,Nucleic Acids Research 21:2605を参照のこと。これらの研究者らは、キメラリボザイムが活性であって、しかもRNAリボザイムよりもヌクレアーゼ消化に対して抵抗することを見いだした。キメラリボザイムは自己相補的であり、つまり、ワトソン・クリック型対合鎖が共有結合で結びついている。キメラリボザイムの研究に際して合成された化合物は、キメラリボザイムが安定したハイブリッド二本鎖を含まないという点で、構造研究のために合成され使用された上記のハイブリッド二本鎖分子とは相違している。こうして、DNA結合アームを有するキメラリボザイムがその基質に結合してハイブリッド二本鎖を形成する。Yang,J.H.ら.1990,Biochemistry 29:11156−60を参照のこと。また、Sawata,S.ら,1993,Nucleic Acids Research 21:5656−60;Hendry,P.ら,1992,Nucleic Acids Research 20:5737−41;Shimayama,T.ら,1993,Nucleic Acids Research 21:2605も参照のこと。リボザイムはRNA基質の開裂を触媒し、それゆえハイブリッド二本鎖が溶解される。
2.2. 真核細胞における部位特異的遺伝的変異
分子生物学の分野に習熟した人達は、多くの場合に、単に新しいポリ核酸配列（すなわち、新しい遺伝子）を標的真核細胞の中に導入するのではなく、むしろ標的細胞中の特定の既存遺伝子を改変することが望まれていることを認識している。標的細胞は培養下で用いたり、またはトランスジェニック動物を作出するために用いることができる。
培養下の真核細胞にDNAを導入するための様々な技法が開発されている。こうした技法として、リン酸カルシウム沈殿およびDEAE−デキストラン媒介エンドサイトーシス、エレクトロポレーション、リポソーム媒介融合、そして複製能のないウイルスによる形質導入が挙げられる。しかし、このような技法は真核細胞に機能性遺伝子を導入することはできても、特定の既存遺伝子に変化（突然変異）を簡単に導入することはできない。導入後、外因性DNAは、相同的組換えにより特定位置にではなく、非正統的組換え（illegitimate recombination）により細胞ゲノムの不特定位置に隔離される。
現在まで、高等真核細胞、すなわち哺乳動物細胞またはトリ細胞に、特定部位のまたは部位特異的な遺伝的変異（突然変異誘発）を導入するための一般的に満足のゆく方法は存在していない。高等真核細胞においては非常に長い（＞1kb）核酸の導入による相同的組換えが可能であるが、これらの技法には入念な選択技術の使用が必要となる。なんとなれば、高等真核細胞における非正統的組換え率は相同的組換え率を上回るからである。Thomas,K.R.＆ Capecchi,M.R.,1987,Cell 52:503を参照のこと。さらに、Valancius,V.＆ Smithies O.,1991,Mol.Cell.Biol.11:4389（真核細胞における線状化プラスミドとスーパーコイルドプラスミドの相同的組換えの比較）を参照のこと。
部位特異的突然変異誘発を達成するための一つのアプローチは、細胞の中に直接一本鎖オリゴデオキシヌクレオチドを導入することであった。この手法は酵母Saccharomyces cerevisiaeにおいて成功裏に採用され、酵母では相同的組換えが高等真核細胞中よりも著しく活発に起こった。Moerschell,R.P.ら,1988,Proc.Natl.Acad.Sci.85:524−28;Yamamoto,T.ら,1992,Yeast 8:935−48を参照のこと。しかし、今日まで、一本鎖オリゴヌクレオチドを用いた哺乳動物細胞またはトリ細胞の形質転換が成功したという報告は皆無である。
標的DNAの構造と哺乳動物における相同的組換え率との関係は、交互のプリンおよびピリミジン塩基の領域、すなわち［ｄ（TG）30・ｄ（AC）30］が組換え率を表すということを示した研究によって推論し得る。これらの成果は培養哺乳動物細胞中の非複製プラスミドの研究において実証された。Wahls,W.P.ら,1990,Mol.Cell.Biol.10:785−93を参照のこと。こうした実験が外因性核酸と細胞ゲノムとの組換えを明らかにするまで拡張されることはなかった。
大腸菌において相同的組換えを促進するタンパク質RecAを用いて真核細胞での相同的組換えを促進させようとする試みがなされた。しかし、こうした試みは明らかに成功しなかった。例えば、W.Bertlingの米国特許第4,950,599号には、真核細胞中でRecAを用いても部位特異的突然変異率が極端に低いこと、そして相同的組換え率が向上しないことが記載されている。D.Zarling ＆ E.Senaの特許公開WO 93/22443およびD.C.Gruenert ＆ K.Kunzelmannの公開WO 94/04032は両方とも嚢胞性繊維症に関係した培養細胞系の遺伝的欠陥を修正することを記述している。これらの刊行物は主として操作方法に関するデータよりもむしろ原理を照明する実験データを載せている。こうして、核に接近させてポリヌクレオチド/RecA複合体を導入するために、ZarlingおよびGruenertは膜透過性にした細胞を利用しているが、こうした細胞は増殖能を持ち合わせていない。さらに、RecAにより促進された相同的組換えが無傷の細胞において起こったと主張する場合でさえ、これらの刊行物はその頻度の定量的概算値をまったく提示していない。かくして、原核生物RecAの使用は、生存真核細胞における相同的組換え率が相同的組換えの自然発生率よりも顕著に高いことを納得できる程度に明示していない。
3. 発明の概要
本発明は、デオキシリボヌクレオチドとリボヌクレオチドの両方を含み、対象の遺伝子と相同性の、単一の、共有結合で結びついた二本鎖オリゴヌクレオチドに関する。遺伝的変異を生み出すために、相同領域内に１個またはそれ以上の非対応（以後「異種」または「ミューテーター」と言う）塩基対が存在する。相同的組換えの正常な構成的細胞過程は標的ゲノム部位にミューテーターヌクレオチドを挿入させる。本発明の二本鎖オリゴヌクレオチド（以後「キメラベクター」と言う）は、対象となる遺伝子に異種塩基対を導入することによって該遺伝子を特異的に改変するために用いることができる。異種塩基対は対象の遺伝子と異なる塩基対、または対象の遺伝子に存在するものに加えた塩基対（挿入）であり得、また、異種塩基対は対象の遺伝子中に存在する塩基対の非存在（欠失）であり得る。本発明は、幾分かは、ベクター中に約15〜50塩基対のハイブリッド二本鎖核酸の領域を含めると、対象遺伝子の変異率が非常に増加するという知見に基づいている。異種塩基対の領域が１〜50塩基対である場合、異種塩基対は本発明のベクター中にホモ二本鎖かハイブリッド二本鎖のどちらかとして存在し得る。異種塩基対が50塩基対より長い場合、それらはホモ二本鎖として存在することが好適である。
ベクターは、真核細胞への核酸の導入を可能にする任意の公知方法によって標的細胞の中に導入することができる。理論によって拘束されないが、キメラベクターは、標的細胞の組換え／修復機構によって取り込まれ、遺伝子変換または相同的組換えにより標的遺伝子を変化させると考えられる。
【図面の簡単な説明】
図１は、２つのキメラベクターの模式図を示す。符号の説明は次のとおりである。1:第一鎖、2:第二鎖、3:異種領域、4:相同領域、5:リンカー、6:連結部位。
Figure 0003585238
図1Aは、Ｒ−Ｄ−Ｒ型の連結されたキメラベクターである。
図1Bは、単一の3'および5'末端をもつＲ−Ｄ−Ｒ型のヘアピンキメラベクターである。
5. 発明の詳細な説明
5.1. 本発明のキメラベクターの説明
本発明は、デオキシリボース含有塩基とリボース含有塩基の両方を含む二本鎖核酸を意図している。それらはDNAとRNAの両領域を含み、それゆえ「キメラベクター」と称される。キメラベクターのリボヌクレオチドの2'−Ｏはメチル化され得る。また、ホスホジエステルはどれもホスホロチオジエステルまたはメチホスホノジエステルで置換することができる。
本発明のキメラベクターは単一の核酸ポリマーである。従って、本発明のキメラベクターはワトソン・クリック型塩基対を形成していない少なくとも１塩基、通常は３または４塩基、の少なくとも１つの領域を含まねばならない。これらの不対領域はワトソン・クリック型塩基対の２本の鎖の間のリンカーとして利用される。不対ヌクレオチド領域を有する合成された他のキメラヌクレオチドと対照的に、キメラベクターは酵素活性がない。すなわち、それらは化学反応を触媒しないか、または、それら自体がATPのような生物学的エネルギー源の非存在下で化学反応を受ける。
好ましい実施態様では、リンカーの塩基はデオキシリボヌクレオチドである。ポリマーの3'および5'末端が相補鎖の隣接ヌクレオチドにワトソン・クリック型塩基対合されるように、２つのリンカーをもつキメラベクターを構築することができる。その後、それらは、キメラベクターが単一の連続した環状核酸ポリマーを形成するように連結させることができる。
キメラベクターの残っている実質的に全部の塩基はワトソン・クリック型塩基対を形成する。ここで用いる「塩基がワトソン・クリック型対合する」または「それらが二本鎖核酸を形成する」という記述は、適当な温度および塩条件下でそれらが塩基対または二本鎖核酸を形成しうることを意味すると理解すべきである。いくつかの低塩および／または高温条件下では、ワトソン・クリック型塩基対が熱力学的に安定であることをやめて、二本鎖核酸が融解または変性を起こしうると理解すべきである。また、１個または２個の塩基対ミスマッチは本発明の操作可能性に影響を及ぼさないことを認識すべきである。
本発明キメラベクターは、標的遺伝子に変化（突然変異）を特異的に導入することを目的としたものである。変換の遺伝子部位は、標的部位の配列と同じ（相同である）配列（以後、相同領域と言う）をもつようにキメラベクターの一部を選択することによって決定される。キメラベクター配列と標的遺伝子の間で異なる領域は異種領域と称される。キメラベクターは標的遺伝子に対して異種であるが、ベクターのこの領域においてヘテロ二本鎖でないことに注意されたい。本発明の好ましい実施態様によれば、各キメラベクターには介在異種領域に隣接する２つの相同領域が存在し、これら３つの領域はすべて単一の連続した二本鎖核酸中に存在する。さらに、本発明によれば、各相同領域はハイブリッド二本鎖核酸の部分を含んでいる。ハイブリッド二本鎖の部分は少なくとも４塩基対、好ましくは８塩基対、より好ましくは約20〜30塩基対でありうる。キメラベクターの機能は、3'および5'末端の互いへの連結を可能にするように配置された、ハイブリッド二本鎖の領域内のホモ二本鎖のジヌクレオチド塩基対によって影響されることはない。２つの相同領域の合計の鎖長は少なくとも20塩基対、好ましくは40〜60塩基対でありうる。
本発明によると、ホモ二本鎖核酸の領域はベクターのハイブリッド二本鎖／相同領域の間に配置することができる。介在するホモ二本鎖は異種領域を含むことができる。異種領域が約50塩基対以下、好ましくは約20塩基対以下である場合には、ホモ二本鎖領域の介在は任意である。異種領域が約20塩基対を越える場合は、異種領域を含むホモ二本鎖を介在させることが好適である。
5.2. 本発明のキメラベクターの構築
本発明のキメラベクターは任意の方法で合成することができる。キメラベクターの最も簡便な合成法は、固相DNA合成で用いる技法の変法によるものである。Caruthers,M.H.,1985,Science 230:281−85;Itakura,K.ら,1984,Ann.Rev/Biochem.53:523−56を参照のこと。RNAおよびキメラ核酸の合成を可能にする変法は、Scaringe,S.A.ら,1990,Nucleic Acids Research 18:5433−41;Usman,N.ら,1992,Nucleic Acids Research 20:6695−99;およびSwiderski,P.M.ら,1994,Anal.Biochem 216:83−88に記述されており、これらの全体を参考としてここに組み入れるものとする。キメラ核酸の合成に関する最近の進展は、Usman,N.＆ Cedergren,R.,1992,Trends Bioch.Sci.17:334−９に概説されている。
２つのハイブリッド二本鎖領域間にホモ二本鎖領域が介在したキメラベクターは半合成法を使って構築することができる。ヘアピンコンホメーションを有する２つの合成キメラポリ核酸を構築すべきである。２つの異なる制限酵素消化産物のオーバーラップに相補的なオーバーラップ付着末端をもつ、２つのキメラ核酸の遊離5'および3'末端を構築する。相補的な制限酵素消化末端をもつホモ二本鎖領域を用意する。クローン化DNA断片の両末端への制限酵素部位の付加は当業者によく理解された技法を用いて行うことができ、例えば、限定するものではないが、伸長プライマーを用いるPCR増幅または制限部位を含むリンカーの平滑末端連結がある。２つのキメラヌクレオチドとホモ二本鎖領域は通常の酵素法により連結させることができる。キメラオリゴヌクレオチドが両末端で連結された産物は、非変性条件下でTrisホウ酸EDTA緩衝液にて６％ポリアクリルアミドゲル中で電気泳動を行うことにより、不完全に反応した基質から分離することができる。線状のキャップされた分子は拘束されて、これらの条件下ではより遅く泳動する。
本発明においては自然界に存在するヌクレオチドのみを含むキメラベクターを使用することができる。約20リボヌクレオチドのハイブリッド二本鎖領域を含むキメラベクターは、in vitroでRNase Hに耐性であることが判明した。酵素分解に対する耐性は、リボヌクレオチドを2'−Ｏメチル化リボヌクレオチドで置換することによっても得られる。加えてまたは別途、核酸のホスホジエステル結合をホスホロチオジエステルで置換してもよい。Shimayama,T.ら,1993,Nucleic Acids Research 21:2605を参照のこと。アラビノース含有ヌクレオチドも使用できる。ここで用いる「核酸」という用語は、こうした修飾核酸を包含するものである。
5.3. 本発明のキメラベクターの使用
本発明のキメラベクターは、標的細胞のゲノムの特定位置に突然変異を起こさせるために使用される。標的細胞のゲノムの特定位置はその核酸配列（以後、標的配列と言う）によって定められる。本発明によると、ハイブリッド二本鎖のいくつかの領域の存在を別にすれば、相同領域が標的配列と同一であるキメラベクターが構築される。導入しようとする変化は異種領域によってコードされる。この変化は該配列の１個以上の塩基の変化または１個以上の塩基の付加でありうる。標的配列の変化が約20個以下の塩基の付加である場合、本発明はハイブリッド二本鎖の１つまたは２つの領域を使って実施できる。標的配列の変化が約50個以上の塩基の付加である場合は、異種領域をホモ二本鎖領域内に含ませることが好ましい。
本発明を実施するには、キメラベクターを標的細胞の核の中に導入することが必要である。こうした導入を起こさせる方法はどれも使用できる。かかる方法として、エレクトロポレーション、DEAE−デキストラン、リン酸カルシウム沈殿、リポソーム媒介融合（リポフェクション）、そして直接注入が挙げられる。エレクトロポレーションが特に適している。
本発明の一実施態様において、キメラベクターはトランスジェニック動物を作出するために用いられる。Brinster,R.L.ら,1989,Proc.Natl.Acad.Sci.86:7087に記載の方法に従って、卵の前核にキメラベクターを導入することができる。さらに、T.E.WagnerおよびP.C.Hoppeの米国特許第4,873,191号を参照のこと。上記文献の内容をそのままここに参考として組み入れるものとする。別法として、キメラベクターを胚性幹細胞に導入し、その胚性幹細胞と正常な芽細胞との凝集によってもキメラ動物を作ることができる。トランスジェニック動物は、Capecchi,M.R.,1989,Science 244:1288（その全体を参考としてここに組み入れる）に記載の方法に従って、キメラ動物の子孫として得ることができる。
エレクトロポレーションを用いると、10,000個の処理細胞につき１個程度の細胞が標的配列で特異的に突然変異を起こす（以後「形質転換された」と言う）。かくして、本発明の実施には、突然変異を起こしていない大多数の細胞の中から形質転換された細胞を選別する方法の使用が含まれる。一実施態様において、細胞の形質転換は生育に有利な性質を付与する。生育に有利な性質の非限定的な例として、薬剤耐性、生育調節の変更および代謝産物利用能の変更が挙げられる。別の実施態様では、選別方法としてネガティブ選別を用いる。この方法では、形質転換された細胞が選別条件下で増殖できなくなり、一方、非形質転換細胞は増殖中の細胞を選択的に破壊する条件にさらすことにより除かれる。
また、形質転換細胞は免疫蛍光で検出しうる細胞表面抗原の改変された表現型をもつことができ、この場合は蛍光活性化セルソーター（Fluorescence Activated Cell Sorter）を使って選別することができる。
トランスジェニック動物を前核注入により作出する場合のように、細胞の中にキメラベクターを導入する方法が直接注入である場合は、形質転換率が細胞10,000個につき１個より多くなる。その結果、選別の必要性がかなり軽減される。
一般に、キメラベクターの有効量はエレクトロポレーションで形質転換しようとする培養細胞100万個あたりキメラベクター10〜1000ngの範囲である。
6. 実施例
6.1. 実施例1:Ustilago菌におけるin vivo活性
野生型のUstilagoは機能性ura−３遺伝子（その産物はウラシル生合成経路の一部をなす）をもっている。野生型Ustilagoを5'−fluororotic acid（5FOA）培地で生育させると、細胞はウラシル生合成経路へのこの酸の取込みのために死滅する。ura−３遺伝子に突然変異が起こってura−3 mRNAが産生されなくなると、5FOA培地上でも細胞は生き残る。
内因性ura−３遺伝子の配列は当技術分野で知られている。一組の実験において、この配列の塩基358をチミジンからアデニンに変えた。この変異は機能不全タンパク質をもたらす。
キメラベクターを次のように合成した：
塩基358で突然変異を起こさせるためのベクター（358 RNAベクター）：
Figure 0003585238
358ベクターはヘアピンコンホメーションをとる。下線部分の塩基はリボ核酸残基を示す。太字はミューテーター（異種領域）を示す。イタリック体で記した「Ｔ」は不対合塩基を示す。
対照として使用するために、同一の配列をもつがリボ核酸を含まないベクターも構築した。このベクターではウラシルの代わりにチミジンが用いられた。
塩基358で突然変異を起こさせるための対照ベクター（DNA 358ベクター）
Figure 0003585238
このベクターもヘアピンコンホメーションをとる。この場合も太字の残基がミューテーターである。
in vivo形質転換実験を行うにあたり、当技術分野で公知の方法に従ってU.maydis細胞（107個）から50μｌ形質転換緩衝液中106個の回収率でプロトプラストを作り、異なる量のキメラベクターまたは均質（DNAのみ）ベクターをプロトプラストと37℃で混合してトランスフェクトした。次に細胞を選択培地にまき、生存コロニー（形質転換体）の数を数えた。結果を以下の表に示す。
Figure 0003585238
これらのデータは、RNA358ベクターによる細胞のトランスフェクションが対応するDNAベクターを用いたトランスフェクションよりも大幅に細胞の生存を高めることを示している。
6.2. NIH 3T3細胞の形質転換
NIH 3T3細胞は良性の（制御できる）増殖特性を有するヒト細胞である。悪性の（制御できない）増殖特性は、Gly12をThrで置き換えるがん遺伝子Ｈ−rasの単一の点突然変異によって付与される。かくして、突然変異Ｇ→T12は容易に選択可能な増殖特性の変化を生じさせる。Taparowsky,E.ら,1982,Nature 300:762;Sukumar S.ら,1983,Nature 306:658を参照のこと。
Ｇ→T12突然変異を誘導するために、次の配列を有するキメラベクターを構築した：
Figure 0003585238
この配列は通常の一文字表記で表してある。更なる特徴として、RNAには下線が引いてあり、不対合塩基はイタリック体で、そしてミューテーター塩基は太字で示してある。環化後、キメラベクターは２つのトリチミジニル配列によって実質的に相補的な２つの鎖に分割され、そしてリボース含有ヌクレオチドはすべてこれら２つの鎖の一方にのみ存在することに注目されたい。
2'−OMeリボース塩基を用いて、４個のデオキシリボース残基に隣接する１つ（Ｒ）および２つ（Ｒ−Ｄ−Ｒ）のハイブリッド二本鎖領域をそれぞれ有する２つの型のキメラベクターを合成した。Ｒ−Ｄ−Ｒ型は上記の配列番号３に示され、Ｒ型は塩基６−９（CGAC）がデオキシヌクレオチドであったこと以外は同一である。5'および3'末端はデオキシヌクレオチドであることに注目されたい。組換えDNA法で用いるものと同じDNAリガーゼ法を用いて合成後のキメラベクターを環化させた。連結後、環化したキメラベクターをD600ゲル（AT Biochem,Malvern,PA）中での分離用電気泳動を２回繰り返すことにより基質から単離した。
対照のベクターは次のものであった:1）ハイブリッド二本鎖を欠いている同一の配列（データを示した、「ホモ二本鎖」）;2）配列5'−GCCCACACCGACGGCGCCACCAC−3'（配列番号４）を有する不対合DNA（データを示した、「sDNA」）;3）異種領域を含まない、それゆえミューテーターヌクレオチドを含まないキメラベクター（データを示さず）。
この実験はエレクトロポレーション法を使ってNIH 3T3細胞（１×106個）を形質転換することにより実施した。エレクトロポレーション後、細胞を４×103個/cm2の密度でまき、14日間培養した。フォーカス形成細胞をクリスタルバイオレットで染色して形質転換体を視覚化した。陽性対照として、H rasのT12型をコードするプラスミドpT24を用いた。この対照を用いて、トランスフェクトされたNIH 3T3細胞中における非正統的組換えレベルを測定した。実験を５回繰り返し、その結果を以下の表に要約して示す。以下に示した結果に加えて、ミューテーターコドンを含まないキメラベクターを使用した対照実験では、NIH 3T3細胞の形質転換フォーカスが全く現れなかった。
Figure 0003585238
これらの結果から、キメラベクターは相同的組換えにより特定の突然変異を導入して哺乳動物細胞を形質転換したことがわかる。この実験での形質転換率は、全突然変異Ｈ−ras遺伝子を含むpT24陽性対照ベクターを用いたトランスフェクションにおいて観察された非正統的組換えによる形質転換率よりも高かった。かくして、キメラベクターを用いることにより、非正統的組換え率よりも高い、哺乳動物細胞での相同的組換え率が達成されたことになる。
配列表
配列番号:1
配列の長さ:37塩基対
配列の型：核酸
鎖の数：自己相補的（self complementary）
トポロジー：直鎖状
配列の種類:DNA/RNA
配列の特徴：
特徴を表す記号：−
存在位置:19..32
他の情報:/ラベル＝ａ
／注＝“RNA"
配列
Figure 0003585238
配列番号:2
配列の長さ:37塩基対
配列の型：核酸
鎖の数：自己相補的
トポロジー：直鎖状
配列の種類:DNA
配列
Figure 0003585238
配列番号:3
配列の長さ:53塩基対
配列の型：核酸
鎖の数：自己相補的
トポロジー：直鎖状
配列の種類:DNA/RNA
配列の特徴：
特徴を表す記号：−
存在位置:2..5
他の情報:/ラベル＝ｂ
／注＝“RNA"
配列の特徴：
特徴を表す記号：−
存在位置:10..21
他の情報:/ラベル＝ｄ
／注＝“RNA"
配列の特徴：
特徴を表す記号：−
存在位置:51..52
他の情報:/ラベル＝ｆ
／注＝“RNA"
配列
Figure 0003585238
配列番号:4
配列の長さ:23塩基対
配列の型：核酸
鎖の数：自己相補的
トポロジー：直鎖状
配列の種類:DNA
配列
Figure 0003585238

Claims (4)

  1. 多くても１つの3'末端と１つの5'末端をもつキメラ核酸であって、
    a.不対領域が前記の核酸を第一鎖と第二鎖に分離するように配置されている、連続した不対塩基の領域；
    b.第一鎖の塩基が第二鎖の塩基に対応している、鎖長が少なくとも15塩基対のワトソン・クリック型塩基対を形成した核酸の領域；
    を含んでなり、その際、
    （ｉ）第一鎖は2'−Ｏまたは2'−OMeリボースで構成された連続した少なくとも３ヌクレオチドの領域を含み、これらのヌクレオチドがハイブリッド二本鎖としてワトソン・クリック型塩基対を形成しており、
    （ii）ワトソン・クリック型塩基対を形成した核酸の領 域は、標的遺伝子配列に相同な２つの領域を含み、これ ら２つの相同領域がハイブリッド二本鎖の部分を含み、 これらの相同領域の間には標的遺伝子配列に変異を引き 起こす配列を含む異種領域が介在している、
    ことを特徴とするキメラ核酸。
  2. 第一鎖が２つのハイブリッド二本鎖領域を形成する2'−Ｏまたは2'−OMeリボースで構成された連続ヌクレオチドの２つの領域を含み、各ハイブリッド二本鎖領域は少なくとも４塩基対の長さであり、そして少なくとも１塩基対のホモ二本鎖の介在領域が２つのハイブリッド二本鎖領域間に配置されており、前記のホモ二 本鎖の介在領域が異種領域を含む、請求項１に記載のキメラ核酸。
  3. 核をもつ細胞または細胞集団のゲノムの標的配列に所定の変異を導入する方法であって、
    a.標的配列に相同な２つの領域と、それらの間に配置された、前記の変異をコードする異種領域と、を含む請求項１または２に記載のキメラ核酸を用意し、
    b.該キメラ核酸を該細胞の核内に維持して、該キメラ核 酸と前記の標的配列が遺伝的組換えを起こすようにする、
    ことを含んでなる方法。
  4. 非ヒトトランスジェニック動物の作製に用いるための、請求項１または２に記載のキメラ核酸。
JP51636795A 1993-12-09 1994-12-09 真核細胞における部位特異的突然変異誘発のための化合物および方法 Expired - Fee Related JP3585238B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16430393A 1993-12-09 1993-12-09
US164,303 1993-12-09
PCT/US1994/014181 WO1995015972A1 (en) 1993-12-09 1994-12-09 Compounds and methods for site-directed mutations in eukaryotic cells

Publications (2)

Publication Number Publication Date
JPH09506511A JPH09506511A (ja) 1997-06-30
JP3585238B2 true JP3585238B2 (ja) 2004-11-04

Family

ID=22593886

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51636795A Expired - Fee Related JP3585238B2 (ja) 1993-12-09 1994-12-09 真核細胞における部位特異的突然変異誘発のための化合物および方法

Country Status (15)

Country Link
US (3) US5565350A (ja)
EP (1) EP0733059B1 (ja)
JP (1) JP3585238B2 (ja)
KR (1) KR100386337B1 (ja)
CN (2) CN1048254C (ja)
AT (1) ATE196311T1 (ja)
AU (1) AU691550B2 (ja)
CA (1) CA2178729A1 (ja)
DE (2) DE733059T1 (ja)
DK (1) DK0733059T3 (ja)
ES (1) ES2149962T3 (ja)
GR (1) GR3034988T3 (ja)
NZ (1) NZ278490A (ja)
PT (1) PT733059E (ja)
WO (1) WO1995015972A1 (ja)

Families Citing this family (800)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0952855B1 (en) * 1991-07-03 2005-07-27 Meditech Research Limited Use of hyaluronan in gene therapy
US6335434B1 (en) 1998-06-16 2002-01-01 Isis Pharmaceuticals, Inc., Nucleosidic and non-nucleosidic folate conjugates
US8153602B1 (en) 1991-11-19 2012-04-10 Isis Pharmaceuticals, Inc. Composition and methods for the pulmonary delivery of nucleic acids
US20020108136A1 (en) * 1997-03-21 2002-08-08 Sri Transgenic animals produced by homologous sequence targeting
IL107150A0 (en) * 1992-09-29 1993-12-28 Isis Pharmaceuticals Inc Oligonucleotides having a conserved g4 core sequence
ATE247128T1 (de) 1993-09-03 2003-08-15 Isis Pharmaceuticals Inc Aminoderivatisierte nukleoside und oligonukleoside
US6420549B1 (en) 1995-06-06 2002-07-16 Isis Pharmaceuticals, Inc. Oligonucleotide analogs having modified dimers
US5760012A (en) * 1996-05-01 1998-06-02 Thomas Jefferson University Methods and compounds for curing diseases caused by mutations
US5731181A (en) * 1996-06-17 1998-03-24 Thomas Jefferson University Chimeric mutational vectors having non-natural nucleotides
US7812149B2 (en) 1996-06-06 2010-10-12 Isis Pharmaceuticals, Inc. 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
US9096636B2 (en) * 1996-06-06 2015-08-04 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
US5898031A (en) 1996-06-06 1999-04-27 Isis Pharmaceuticals, Inc. Oligoribonucleotides for cleaving RNA
US20030044941A1 (en) 1996-06-06 2003-03-06 Crooke Stanley T. Human RNase III and compositions and uses thereof
ATE264864T1 (de) * 1997-03-03 2004-05-15 Applera Corp Verbesserte chimäre oligonukleotidvektoren
US5948653A (en) * 1997-03-21 1999-09-07 Pati; Sushma Sequence alterations using homologous recombination
US6524613B1 (en) 1997-04-30 2003-02-25 Regents Of The University Of Minnesota Hepatocellular chimeraplasty
GB9711015D0 (en) * 1997-05-28 1997-07-23 Zeneca Ltd Improvements in or relating to organic compounds
DE69834038D1 (de) 1997-07-01 2006-05-18 Isis Pharmaceutical Inc Zusammensetzungen und verfahren zur verabreichung von oligonukleotiden über die speiseröhre
WO1999007865A1 (en) * 1997-08-05 1999-02-18 Kimeragen, Inc. The use of mixed duplex oligonucleotides to effect localized genetic changes in plants
US7102055B1 (en) 1997-11-18 2006-09-05 Pioneer Hi-Bred International, Inc. Compositions and methods for the targeted insertion of a nucleotide sequence of interest into the genome of a plant
AU760113C (en) 1997-11-18 2004-04-22 Pioneer Hi-Bred International, Inc. Compositions and methods for genetic modification of plants
EP1032692A1 (en) 1997-11-18 2000-09-06 Pioneer Hi-Bred International, Inc. Targeted manipulation of herbicide-resistance genes in plants
EP0945507A1 (de) * 1998-03-27 1999-09-29 Boehringer Mannheim Gmbh Tumorspezifische Expressionskontrollregion und deren Verwendung
US20040186071A1 (en) 1998-04-13 2004-09-23 Bennett C. Frank Antisense modulation of CD40 expression
US6010907A (en) 1998-05-12 2000-01-04 Kimeragen, Inc. Eukaryotic use of non-chimeric mutational vectors
US6004804A (en) 1998-05-12 1999-12-21 Kimeragen, Inc. Non-chimeric mutational vectors
US6841539B1 (en) 1998-05-21 2005-01-11 Isis Pharmaceuticals, Inc. Compositions and methods for topical delivery of oligonucleotides
AU745880B2 (en) * 1998-05-21 2002-04-11 Isis Pharmaceuticals, Inc. Compositions and methods for non-parenteral delivery of oligonucleotides
US6693185B2 (en) 1998-07-17 2004-02-17 Bayer Bioscience N.V. Methods and means to modulate programmed cell death in eukaryotic cells
DE19836098A1 (de) 1998-07-31 2000-02-03 Hoechst Schering Agrevo Gmbh Pflanzen, die eine modifizierte Stärke synthetisieren, Verfahren zur Herstellung der Pflanzen, ihre Verwendung sowie die modifizierte Stärke
EP1117762A4 (en) 1998-09-29 2004-02-25 Gamida Cell Ltd METHOD FOR CONTROLLING PROLIFERATION AND DIFFERENTIATION OF STEM CELLS AND PRECELLER CELLS
US6077709A (en) 1998-09-29 2000-06-20 Isis Pharmaceuticals Inc. Antisense modulation of Survivin expression
AU773808B2 (en) 1998-11-09 2004-06-10 Bayer Cropscience Aktiengesellschaft Nucleic acid molecules from rice and their use for the production of modified starch
US6438561B1 (en) * 1998-11-19 2002-08-20 Navigation Technologies Corp. Method and system for using real-time traffic broadcasts with navigation systems
US6917882B2 (en) 1999-01-19 2005-07-12 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US6368861B1 (en) 1999-01-19 2002-04-09 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
AU2415200A (en) * 1999-01-18 2000-08-01 Maxygen, Inc. Methods of populating data structures for use in evolutionary simulations
US6376246B1 (en) 1999-02-05 2002-04-23 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US20030054390A1 (en) * 1999-01-19 2003-03-20 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US7024312B1 (en) 1999-01-19 2006-04-04 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US6961664B2 (en) 1999-01-19 2005-11-01 Maxygen Methods of populating data structures for use in evolutionary simulations
EP1072010B1 (en) * 1999-01-19 2010-04-21 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US20070065838A1 (en) 1999-01-19 2007-03-22 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6127124A (en) * 1999-01-20 2000-10-03 Isis Pharmaceuticals, Inc. Fluorescence based nuclease assay
EP1165132B1 (en) * 1999-04-08 2011-10-19 Intercell USA, Inc. Dry formulation for transcutaneous immunization
US7098192B2 (en) 1999-04-08 2006-08-29 Isis Pharmaceuticals, Inc. Antisense oligonucleotide modulation of STAT3 expression
EP2055779A3 (en) 1999-05-07 2009-08-12 E.I. Dupont De Nemours And Company Auxin transport proteins
US6656730B1 (en) 1999-06-15 2003-12-02 Isis Pharmaceuticals, Inc. Oligonucleotides conjugated to protein-binding drugs
US6271360B1 (en) 1999-08-27 2001-08-07 Valigen (Us), Inc. Single-stranded oligodeoxynucleotide mutational vectors
AR025996A1 (es) 1999-10-07 2002-12-26 Valigen Us Inc Plantas no transgenicas resistentes a los herbicidas.
EP1218524A2 (en) * 1999-10-07 2002-07-03 Valigen Inc. Compositions and methods for plant genetic modification
US7430477B2 (en) 1999-10-12 2008-09-30 Maxygen, Inc. Methods of populating data structures for use in evolutionary simulations
US7668658B2 (en) 1999-10-13 2010-02-23 Sequenom, Inc. Methods for generating databases and databases for identifying polymorphic genetic markers
US7820878B2 (en) * 1999-11-19 2010-10-26 Kyowa Hakko Kirin Co., Ltd. Production of ungulates, preferably bovines that produce human immunoglobulins
US7414170B2 (en) * 1999-11-19 2008-08-19 Kirin Beer Kabushiki Kaisha Transgenic bovines capable of human antibody production
US7074983B2 (en) 1999-11-19 2006-07-11 Kirin Beer Kabushiki Kaisha Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin
WO2001035735A1 (en) * 1999-11-19 2001-05-25 Hematech, Llc Production of ungulates, preferably bovines that produce human immunoglobulins
US6261840B1 (en) 2000-01-18 2001-07-17 Isis Pharmaceuticals, Inc. Antisense modulation of PTP1B expression
US20020055479A1 (en) 2000-01-18 2002-05-09 Cowsert Lex M. Antisense modulation of PTP1B expression
US6897020B2 (en) * 2000-03-20 2005-05-24 Newlink Genetics Inc. Methods and compositions for elucidating relative protein expression levels in cells
US20060134629A1 (en) * 2000-03-20 2006-06-22 Link Charles J Methods and compositions for elucidating protein expression profiles in cells
US6936467B2 (en) * 2000-03-27 2005-08-30 University Of Delaware Targeted chromosomal genomic alterations with modified single stranded oligonucleotides
CA2404780A1 (en) * 2000-03-27 2001-10-04 University Of Delaware Targeted chromosomal genomic alterations with modified single stranded oligonucleotides
EP1284985A2 (en) * 2000-05-17 2003-02-26 University Of Delaware Plant gene targeting using oligonucleotides
US6686188B2 (en) * 2000-05-26 2004-02-03 Amersham Plc Polynucleotide encoding a human myosin-like polypeptide expressed predominantly in heart and muscle
US6656700B2 (en) 2000-05-26 2003-12-02 Amersham Plc Isoforms of human pregnancy-associated protein-E
US20030017593A1 (en) * 2000-06-05 2003-01-23 Gamper Howard B. Binary hybrid mutational vectors
US7468475B2 (en) 2000-06-16 2008-12-23 Schmuelling Thomas Method for modifying plant morphology, biochemistry and physiology
US6958214B2 (en) 2000-07-10 2005-10-25 Sequenom, Inc. Polymorphic kinase anchor proteins and nucleic acids encoding the same
EP1364008A2 (en) * 2000-07-27 2003-11-26 University Of Delaware Methods for enhancing targeted gene alteration using oligonucleotides
US6875907B2 (en) 2000-09-13 2005-04-05 Pioneer Hi-Bred International, Inc. Antimicrobial peptides and methods of use
WO2002026967A2 (en) * 2000-09-25 2002-04-04 Thomas Jefferson University Targeted gene correction by single-stranded oligodeoxynucleotides
US20020123474A1 (en) * 2000-10-04 2002-09-05 Shannon Mark E. Human GTP-Rho binding protein2
US7560622B2 (en) 2000-10-06 2009-07-14 Pioneer Hi-Bred International, Inc. Methods and compositions relating to the generation of partially transgenic organisms
US20020142397A1 (en) * 2000-12-22 2002-10-03 Philippe Collas Methods for altering cell fate
EP1356035B1 (en) 2000-12-22 2011-03-16 Kyowa Hakko Kirin Co., Ltd. Methods for cloning non-human mammals using reprogrammed donor chromatin or donor cells
US7491534B2 (en) 2000-12-22 2009-02-17 Kirin Holdings Kabushiki Kaisha Methods for altering cell fate to generate T-cells specific for an antigen of interest
WO2002059337A1 (en) * 2001-01-26 2002-08-01 Georgetown University School Of Medicine Anti-apoptopic gene scc-s2 and diagnostic and therapeutic uses thereof
EP1414840A4 (en) * 2001-03-27 2005-04-13 Univ Delaware GENOMIC APPLICATIONS FOR MODIFIED OLIGONUCLEOTIDES
WO2002081640A2 (en) * 2001-04-06 2002-10-17 Georgetown University Gene shinc-1 and diagnostic and therapeutic uses thereof
WO2002081641A2 (en) * 2001-04-06 2002-10-17 Georgetown University Gene scc-112 and diagnostic and therapeutic uses thereof
AU2002258728A1 (en) 2001-04-06 2002-10-21 Georgetown University Gene brcc-3 and diagnostic and therapeutic uses thereof
WO2002081639A2 (en) * 2001-04-06 2002-10-17 Georgetown University Gene brcc2 and diagnostic and therapeutic uses thereof
US20030045830A1 (en) * 2001-04-17 2003-03-06 De Bizemont Therese Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis
US20040063922A1 (en) * 2001-04-17 2004-04-01 Conrad Charles A. Methods and compositions for catalytic DNA exchange in a sequence specific manner
US7053195B1 (en) * 2001-06-12 2006-05-30 Syngenta Participatious Ag Locked nucleic acid containing heteropolymers and related methods
ES2372321T3 (es) 2001-06-20 2012-01-18 Genentech, Inc. Composiciones y métodos para el diagnóstico y tratamiento de un tumor de pulmón.
US7803915B2 (en) 2001-06-20 2010-09-28 Genentech, Inc. Antibody compositions for the diagnosis and treatment of tumor
EP2270024B1 (en) 2001-06-21 2018-10-24 Ionis Pharmaceuticals, Inc. Antisense modulation of superoxide dismutase 1, soluble expression
EP1925672A1 (en) 2001-06-22 2008-05-28 Syngeta Participations AG Abiotic stress responsive polynucleotides and polypeptides
US6964950B2 (en) 2001-07-25 2005-11-15 Isis Pharmaceuticals, Inc. Antisense modulation of C-reactive protein expression
US7425545B2 (en) 2001-07-25 2008-09-16 Isis Pharmaceuticals, Inc. Modulation of C-reactive protein expression
US20030096772A1 (en) 2001-07-30 2003-05-22 Crooke Rosanne M. Antisense modulation of acyl CoA cholesterol acyltransferase-2 expression
US7407943B2 (en) 2001-08-01 2008-08-05 Isis Pharmaceuticals, Inc. Antisense modulation of apolipoprotein B expression
US7227014B2 (en) 2001-08-07 2007-06-05 Isis Pharmaceuticals, Inc. Antisense modulation of apolipoprotein (a) expression
AU2002326589B2 (en) * 2001-08-07 2008-06-05 University Of Delaware Compositions and methods for the prevention and treatment of Huntington's disease
AU2002322435A1 (en) * 2001-08-09 2003-02-24 Cibus Genetics Non-transgenic herbicide resistant plants
US7456335B2 (en) * 2001-09-03 2008-11-25 Basf Plant Science Gmbh Nucleic acid sequences and their use in methods for achieving pathogen resistance in plants
NZ531674A (en) 2001-09-18 2009-03-31 Genentech Inc Compositions and methods for the diagnosis and treatment of tumor
EP1427856B1 (en) 2001-09-18 2011-05-11 Carnegie Institution Of Washington Fusion proteins useful for detecting analytes
US7468244B2 (en) * 2001-09-27 2008-12-23 University Of Delaware Polymorphism detection and separation
AU2002341905A2 (en) * 2001-09-27 2003-04-07 University Of Delaware Composition and methods for enhancing oligonucleotide-directed nucleic acid sequence alteration
MXPA04002817A (es) 2001-09-27 2004-07-05 Pioneer Hi Bred Int Polinucleotidos de fitato y metodos de uso.
WO2003027264A2 (en) * 2001-09-27 2003-04-03 University Of Delaware Coisogenic eukaryotic cell collections
ATE516364T1 (de) 2001-10-09 2011-07-15 Isis Pharmaceuticals Inc Antisense-modulation der expression des insulinähnlicher-wachstumsfaktor-bindungsprotei s 5
US6750019B2 (en) 2001-10-09 2004-06-15 Isis Pharmaceuticals, Inc. Antisense modulation of insulin-like growth factor binding protein 5 expression
US6965025B2 (en) 2001-12-10 2005-11-15 Isis Pharmaceuticals, Inc. Antisense modulation of connective tissue growth factor expression
KR20070087247A (ko) 2002-01-02 2007-08-27 제넨테크, 인크. 종양의 진단 및 치료 방법 및 이를 위한 조성물
IL152904A0 (en) 2002-01-24 2003-06-24 Gamida Cell Ltd Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
EP1465982A4 (en) 2002-01-25 2006-06-07 Gamida Cell Ltd PROCESS FOR EXPANSION OF STEM AND PRESERVATIVE CELLS AND EXPANDED CELL POPULATIONS THEREWITH OBTAINED
US20060009409A1 (en) 2002-02-01 2006-01-12 Woolf Tod M Double-stranded oligonucleotides
US20030166282A1 (en) 2002-02-01 2003-09-04 David Brown High potency siRNAS for reducing the expression of target genes
EP1470148B1 (en) 2002-02-01 2012-07-18 Life Technologies Corporation Double-stranded oligonucleotides
US7135326B2 (en) * 2002-02-07 2006-11-14 E. I. Du Pont De Nemours And Company UDP-glucosyltransferases
AU2003211128A1 (en) 2002-02-20 2003-09-09 American Integrated Biologics, Inc. Transgenic production in saliva
AU2003220119A1 (en) * 2002-03-07 2003-09-22 University Of Delaware Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phage beta protein, or hydroxyurea
WO2003087313A2 (en) 2002-04-08 2003-10-23 Pioneer Hi-Bred International, Inc. Enhanced silk exsertion under stress
US7138512B2 (en) * 2002-04-10 2006-11-21 Georgetown University Gene SHINC-2 and diagnostic and therapeutic uses thereof
US7244565B2 (en) * 2002-04-10 2007-07-17 Georgetown University Gene shinc-3 and diagnostic and therapeutic uses thereof
CA2481507A1 (en) 2002-04-16 2003-10-30 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
EP1501863A4 (en) 2002-05-03 2007-01-24 Sequenom Inc KINASE ANCHOR PROTEIN, PEPTIDES AND RELATED METHODS THEREOF
AU2003245878B2 (en) 2002-05-08 2008-01-24 Basf Plant Science Gmbh Methods for increasing oil content in plants
US20030228317A1 (en) * 2002-05-22 2003-12-11 Prafulla Gokhale Gene BRCC-1 and diagnostic and therapeutic uses thereof
US7199107B2 (en) 2002-05-23 2007-04-03 Isis Pharmaceuticals, Inc. Antisense modulation of kinesin-like 1 expression
US20030228558A1 (en) * 2002-06-11 2003-12-11 Bloom William Dennis Method of training brokers in a multi-level marketing business
US20050221326A1 (en) * 2002-06-12 2005-10-06 Avi Orr-Urtreger Oligonucleotides antibodies and kits including same for treating prostate cancer and determining predisposition thereto
AU2003264507A1 (en) * 2002-09-20 2004-04-08 Koken Co., Ltd. Site-specific gene conversion promoter and gene therapeutic
US7229976B2 (en) 2002-09-26 2007-06-12 Isis Pharmaceuticals, Inc. Modulation of forkhead box O1A expression
US20040175722A1 (en) * 2002-10-07 2004-09-09 Kmiec Eric B. Methods and compositions for reducing screening in oligonucleotide-directed nucleic acid sequence alteration
EP1560839A4 (en) 2002-11-05 2008-04-23 Isis Pharmaceuticals Inc CHIMERIC OLIGOMER COMPOUNDS AND THEIR USE IN GENE MODULATION
US9150606B2 (en) 2002-11-05 2015-10-06 Isis Pharmaceuticals, Inc. Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
AU2003291755A1 (en) 2002-11-05 2004-06-07 Isis Pharmaceuticals, Inc. Oligomers comprising modified bases for binding cytosine and uracil or thymine and their use
US9150605B2 (en) * 2002-11-05 2015-10-06 Isis Pharmaceuticals, Inc. Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
KR20050093761A (ko) * 2002-11-08 2005-09-23 헤마테크, 엘엘씨 프리온 단백질 활성이 감소된 트랜스제닉 유제동물 및 그의용도
SI2336318T1 (sl) 2002-11-13 2013-07-31 Genzyme Corporation Protismiselna modulacija ekspresije apolipoproteina B
CA2505801A1 (en) 2002-11-13 2004-05-27 Rosanne Crooke Antisense modulation of apolipoprotein b expression
US7754450B2 (en) 2002-11-15 2010-07-13 Morphotek, Inc. Methods of generating high-production of antibodies from hybridomas created by in vitro immunization
US7144999B2 (en) 2002-11-23 2006-12-05 Isis Pharmaceuticals, Inc. Modulation of hypoxia-inducible factor 1 alpha expression
US7714186B2 (en) 2002-12-19 2010-05-11 Bayer Cropscience Ag Plant cells and plants which synthesize a starch with an increased final viscosity
US7468356B2 (en) 2003-02-11 2008-12-23 Antisense Therapeutics Ltd. Modulation of insulin like growth factor I receptor expression
CA2516042A1 (en) 2003-02-17 2004-09-02 Metanomics Gmbh Preparation of transgenic plants comprising a nucleic acid molecule encoding an l450 polypeptide-exhibiting faster growth and/or increased yield
US7803781B2 (en) 2003-02-28 2010-09-28 Isis Pharmaceuticals, Inc. Modulation of growth hormone receptor expression and insulin-like growth factor expression
US20040185559A1 (en) 2003-03-21 2004-09-23 Isis Pharmaceuticals Inc. Modulation of diacylglycerol acyltransferase 1 expression
EP2365063B1 (de) 2003-03-31 2015-10-14 University Of Bristol Neue pflanzliche Acyltransferase spezifisch für langkettige mehrfach ungesättigte Fettsäuren
US20040205840A1 (en) * 2003-04-11 2004-10-14 Pioneer Hi-Bred International, Inc. Method for reducing gene expression
EP2194135A3 (en) 2003-04-15 2010-10-06 BASF Plant Science GmbH Nucleic acid sequences from yeast encoding proteins associated with abiotic stress response and transformed plant cells and plants with increased tolerance to environmental stress
US7598227B2 (en) 2003-04-16 2009-10-06 Isis Pharmaceuticals Inc. Modulation of apolipoprotein C-III expression
US7399853B2 (en) 2003-04-28 2008-07-15 Isis Pharmaceuticals Modulation of glucagon receptor expression
WO2005002507A2 (en) 2003-06-03 2005-01-13 Isis Pharmaceuticals, Inc. Modulation of survivin expression
US7790691B2 (en) * 2003-06-20 2010-09-07 Isis Pharmaceuticals, Inc. Double stranded compositions comprising a 3′-endo modified strand for use in gene modulation
EP1648914A4 (en) 2003-07-31 2009-12-16 Regulus Therapeutics Inc OLIGOMERIC COMPOUNDS AND COMPOSITIONS USEFUL FOR MODULATING SMALL NON-CODING RNA
CA3037924A1 (en) 2003-08-01 2005-02-10 Basf Plant Science Gmbh Method for the production of polyunsaturated fatty acids in transgenic organisms
EP1654368A2 (en) 2003-08-01 2006-05-10 BASF Plant Science GmbH Process for the production of fine chemicals
US7608751B2 (en) 2003-08-11 2009-10-27 Kweek-En Researchbedruf Agrico B.V. Fungus resistant plants and their uses
US7825235B2 (en) 2003-08-18 2010-11-02 Isis Pharmaceuticals, Inc. Modulation of diacylglycerol acyltransferase 2 expression
US20050053981A1 (en) 2003-09-09 2005-03-10 Swayze Eric E. Gapped oligomeric compounds having linked bicyclic sugar moieties at the termini
AU2004274021B2 (en) 2003-09-18 2009-08-13 Isis Pharmaceuticals, Inc. 4'-thionucleosides and oligomeric compounds
AU2004274942B2 (en) 2003-09-18 2008-02-28 Isis Pharmaceuticals, Inc. Modulation of eIF4E expression
WO2005035548A1 (en) 2003-10-10 2005-04-21 Meditech Research Limited The moduilation of hyaluronan synthesis and degradation in the treatment of disease
CN102174538B (zh) 2003-10-23 2013-06-19 奇尼塔二有限责任公司 检测与抗病毒感染性有关的基因oas1中的突变的方法
US20050191653A1 (en) 2003-11-03 2005-09-01 Freier Susan M. Modulation of SGLT2 expression
JP4901478B2 (ja) 2003-11-17 2012-03-21 ジェネンテック， インコーポレイテッド 造血系起源の腫瘍の治療のための組成物と方法
US20050120397A1 (en) * 2003-11-24 2005-06-02 Hermann Steller Compounds and methods for regulation of spermatid differentiation
ATE524551T1 (de) 2003-12-17 2011-09-15 Cropdesign Nv Pflanzen mit modifizierten wachstumseigenschaften sowie herstellungsverfahren dafür
US7741070B2 (en) 2003-12-24 2010-06-22 Massachusetts Institute Of Technology Gene targets for enhanced carotenoid production
WO2005062923A2 (en) * 2003-12-24 2005-07-14 Massachusetts Institute Of Technology Gene targets for enhanced carotenoid production
US7608699B2 (en) * 2003-12-29 2009-10-27 Rockefeller University Synthetic nuclear localization signal derived from lentiviral integrase and methods of use thereof
JP2007520222A (ja) 2004-01-20 2007-07-26 アイシス ファーマシューティカルズ インコーポレイテッド グルココルチコイドレセプター発現の調節
US7468431B2 (en) 2004-01-22 2008-12-23 Isis Pharmaceuticals, Inc. Modulation of eIF4E-BP2 expression
AU2005216528B2 (en) 2004-02-25 2009-06-04 Pioneer Hi-Bred International, Inc. Novel Bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof
ES2375363T3 (es) 2004-02-27 2012-02-29 Basf Plant Science Gmbh Método para la preparación de ácidos grasos omega-3 insaturados en organismos transgénicos.
JP4567047B2 (ja) 2004-02-27 2010-10-20 ビーエーエスエフ プラント サイエンス ゲーエムベーハー トランスジェニック植物における多価不飽和脂肪酸の製造方法
US8569474B2 (en) 2004-03-09 2013-10-29 Isis Pharmaceuticals, Inc. Double stranded constructs comprising one or more short strands hybridized to a longer strand
US8790919B2 (en) * 2004-03-15 2014-07-29 Isis Pharmaceuticals, Inc. Compositions and methods for optimizing cleavage of RNA by RNase H
WO2005094370A2 (en) * 2004-03-29 2005-10-13 The General Hospital Corporation Oligonucleotide complex compositions and methods of use as gene alteration tools
CA2561741C (en) 2004-04-05 2016-09-27 Alnylam Pharmaceuticals, Inc. Processes and reagents for oligonucleotide synthesis and purification
US20050244869A1 (en) 2004-04-05 2005-11-03 Brown-Driver Vickie L Modulation of transthyretin expression
NZ550106A (en) * 2004-04-22 2009-06-26 Kyowa Hakko Kirin Co Ltd Transgenic animals and uses thereof
US20070072815A1 (en) * 2004-05-04 2007-03-29 Kmiec Eric B Methods and kits to increase the efficiency of oligonucleotide-directed nucleic acid sequence alteration
US7825293B2 (en) 2004-05-28 2010-11-02 Cropdesign N.V. Plants having improved growth characteristics and a method for making the same
US8394947B2 (en) 2004-06-03 2013-03-12 Isis Pharmaceuticals, Inc. Positionally modified siRNA constructs
CA2735315A1 (en) 2004-06-09 2005-12-29 Pioneer Hi-Bred International, Inc. Plastid transit peptides
WO2007087815A2 (en) 2004-12-17 2007-08-09 Metanomics Gmbh Process for the control of production of fine chemicals
EP2080769A3 (en) 2004-07-02 2010-12-01 Metanomics GmbH Process for the production of fine chemicals
US8680062B2 (en) 2004-07-06 2014-03-25 Deliversir Ltd. System for delivering therapeutic agents into living cells and cells nuclei
AU2005261646B2 (en) 2004-07-12 2012-02-02 Cropdesign N.V. Plants having improved growth characteristics and method for making the same
CN101001956B (zh) 2004-07-31 2014-09-24 梅坦诺米克斯有限公司 制备具有更快生长和/或更高产量的生物
DK1786472T3 (da) 2004-08-10 2013-04-15 Genzyme Corp Antisense-modulering af apolipoprotein B-ekspression
CA2576277A1 (en) 2004-08-16 2006-02-23 Cropdesign N.V. Plants having improved growth characteristics and method for making the same
US7884086B2 (en) 2004-09-08 2011-02-08 Isis Pharmaceuticals, Inc. Conjugates for use in hepatocyte free uptake assays
WO2006030442A2 (en) 2004-09-16 2006-03-23 Gamida-Cell Ltd. Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells
CA2580504C (en) 2004-09-17 2013-10-29 Isis Pharmaceuticals, Inc. Enhanced antisense oligonucleotides
EP2053057A3 (en) 2004-09-24 2009-07-15 BASF Plant Science GmbH Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmantal stress
WO2006086821A1 (en) 2004-10-20 2006-08-24 Antisense Therapeutics Ltd ANTISENS MODULATION OF INTEGRIN α4 EXPRESSION
CA2588281A1 (en) 2004-10-29 2006-05-04 Cropdesign N.V. Plants having improved growth characteristics and method for making the same
AR051866A1 (es) 2004-12-24 2007-02-14 Cropdesign Nv Plantas con aumento del rendimiento y metodo de prepracion
EP1831376A1 (en) 2004-12-28 2007-09-12 Pioneer Hi-Bred International, Inc. Improved grain quality through altered expression of seed proteins
JP2008528014A (ja) 2005-01-27 2008-07-31 クロップデザイン エヌ．ブイ． 収量が増加した植物および該植物を作製する方法
WO2006091194A1 (en) 2005-02-23 2006-08-31 North Carolina State University Alteration of tobacco alkaloid content through modification of specific cytochrome p450 genes
EP1871883A1 (en) 2005-03-02 2008-01-02 Metanomics GmbH Process for the production of fine chemicals
EP2573188A2 (en) 2005-03-02 2013-03-27 Metanomics GmbH Process for the production of fine chemicals
EP2045327B8 (en) 2005-03-08 2012-03-14 BASF Plant Science GmbH Expression enhancing intron sequences
EP1869076A2 (en) 2005-03-10 2007-12-26 Genentech, Inc. Methods and compositions for modulating vascular integrity
DE102005013779A1 (de) 2005-03-22 2006-09-28 Basf Plant Science Gmbh Verfahren zur Herstellung von mehrfach ungesättigten C20- und C22-Fettsäuren mit mindestens vier Doppelbindungen in transgenen Pflanzen
EP1707632A1 (de) 2005-04-01 2006-10-04 Bayer CropScience GmbH Phosphorylierte waxy-Kartoffelstärke
CA2604807C (en) 2005-04-19 2018-06-12 Basf Plant Science Gmbh Improved methods controlling gene expression
CA2606270A1 (en) 2005-04-19 2006-10-26 Massachusetts Institute Of Technology Amphiphilic polymers and methods of use thereof
US20070011752A1 (en) * 2005-05-06 2007-01-11 American Integrated Biologics, Inc. Production of human proteins in transgenic animal saliva
WO2006127310A2 (en) 2005-05-25 2006-11-30 Pioneer Hi-Bred International, Inc. Methods for improving crop plant architecture and yield
WO2007008300A2 (en) 2005-05-31 2007-01-18 ECOLE POLYTECHNIQUE FéDéRALE DE LAUSANNE Triblock copolymers for cytoplasmic delivery of gene-based drugs
US8252756B2 (en) 2005-06-14 2012-08-28 Northwestern University Nucleic acid functionalized nanoparticles for therapeutic applications
DE602006019588D1 (de) 2005-06-23 2011-02-24 Basf Plant Science Gmbh Verbesserte verfahren zur herstellung stabil transformierter und fruchtbarer buntmais-pflanzen
BRPI0612710A2 (pt) 2005-07-06 2012-10-02 Cropdesign Nv método para aumentar o rendimento de plantas com relação às plantas de controle, e para produzir uma planta transgênica tendo rendimento aumentado, planta, construção, partes coletáveis de uma planta, produtos, e, uso de um ácido nucleico / gene de tipo ste20 ou variante do mesmo, ou uso de um polipeptìdeo de tipo ste20 ou seu homólogo
DE102005038036A1 (de) 2005-08-09 2007-02-15 Basf Plant Science Gmbh Verfahren zur Herstellung von Arachidonsäure und/oder Eicosapentaensäure in transgenen Nutzpflanzen
WO2007020198A2 (en) 2005-08-12 2007-02-22 Basf Plant Science Gmbh Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress
US7842856B2 (en) 2005-08-25 2010-11-30 The Board Of Trustees Of The University Of Illinois Herbicide resistance gene, compositions and methods
MX2008003389A (es) 2005-09-15 2008-03-27 Cropdesign Nv Plantas que tienen rendimiento incrementado y un metodo para efectuar las mismas.
WO2007039454A1 (en) 2005-09-20 2007-04-12 Basf Plant Science Gmbh Methods for controlling gene expression using ta-siran
GB2431158A (en) 2005-10-13 2007-04-18 Rothamsted Res Ltd Process for the production of arachidonic and/or eicosapentaenoic acid
US8853492B2 (en) 2005-11-07 2014-10-07 Cropdesign N.V. Plants having improved growth characteristics and a method for making the same
EP1948807B1 (en) 2005-11-07 2015-09-30 CropDesign N.V. Plants having improved growth characteristics and a method for making the same
AU2006311089C1 (en) 2005-11-08 2012-11-08 Basf Plant Science Gmbh Use of armadillo repeat (ARM1) polynucleotides for obtaining pathogen resistance in plants
US20090222952A1 (en) 2005-11-08 2009-09-03 Cropdesign N.V. Plants Having Improved Growth Characteristics And A Method For Making The Same
EP1945776A2 (en) 2005-11-10 2008-07-23 Pioneer Hi-Bred International, Inc. Dof (dna binding with one finger) sequences and methods of use
US20070199096A1 (en) 2005-11-14 2007-08-23 E.I. Du Pont De Nemours And Company Compositions and Methods for Altering Alpha- and Beta-Tocotrienol Content
CA2630602A1 (en) 2005-11-21 2007-05-31 Isis Pharmaceuticals, Inc. Modulation of eif4e-bp2 expression
EP1957034A2 (de) * 2005-11-24 2008-08-20 Basf Se Chimäre keratinbindende effektorproteine
US7723574B2 (en) 2005-11-24 2010-05-25 Basf Plant Science Gmbh Process for the production of Δ5-unsaturated fatty acids in transgenic organisms
US8846393B2 (en) 2005-11-29 2014-09-30 Gamida-Cell Ltd. Methods of improving stem cell homing and engraftment
CA2631779C (en) 2005-12-01 2015-10-27 Cropdesign N.V. Plants having improved growth characteristics and methods for making the same
CN101341254A (zh) 2005-12-24 2009-01-07 蒂加斯克乳制品研究中心 反-10，顺-12十八碳二烯酸的生产方法
EP1976567B1 (en) 2005-12-28 2020-05-13 The Scripps Research Institute Natural antisense and non-coding rna transcripts as drug targets
US7592505B2 (en) 2005-12-30 2009-09-22 Pioneer Hi-Bred International, Inc. UDP-xylose synthases (UXS) polynucleotides, polypeptides, and uses thereof
RU2441366C2 (ru) 2006-01-12 2012-02-10 Сайбас Юроп Б.В. Мутанты epsps
US8178751B2 (en) 2006-01-12 2012-05-15 Basf Plant Science Gmbh Use of stomatin (STM1) polynucleotides for achieving a pathogen resistance in plants
PL2161038T3 (pl) 2006-01-26 2014-06-30 Ionis Pharmaceuticals Inc Kompozycje i ich zastosowanie ukierunkowane na huntingtynę
CA2640171C (en) 2006-01-27 2014-10-28 Isis Pharmaceuticals, Inc. 6-modified bicyclic nucleic acid analogs
US7569686B1 (en) 2006-01-27 2009-08-04 Isis Pharmaceuticals, Inc. Compounds and methods for synthesis of bicyclic nucleic acid analogs
EP2388327A1 (en) 2006-01-27 2011-11-23 Isis Pharmaceuticals, Inc. Oligomeric compounds and compositions for the use in modulation of micrornas
BRPI0707413A2 (pt) 2006-02-09 2011-05-03 Pioneer Hi Bred Int genes para aprimoramento da eficiência de utilização do nitrogênio em culturas
GB0603160D0 (en) 2006-02-16 2006-03-29 Rothamsted Res Ltd Nucleic acid
MX2008012252A (es) 2006-03-24 2009-01-14 Basf Plant Science Gmbh Proteinas que se relacionan con la respuesta al estres abiotico y homologos.
EP2441844A1 (en) 2006-03-31 2012-04-18 BASF Plant Science GmbH Plants having enhanced yield-related traits and a method for making the same
AU2007299219A1 (en) 2006-04-05 2008-03-27 Metanomics Gmbh Process for the production of a fine chemical
AR060523A1 (es) 2006-04-19 2008-06-25 Pioneer Hi Bred Int Moleculas de polinucleotidos aislados que corresponden a alelos mutantes y tipo salvaje del gen de maiz d9 y metodos para usarlas
AU2007258117B2 (en) 2006-05-05 2013-05-30 Isis Pharmaceuticals, Inc. Compounds and methods for modulating gene expression
US7666854B2 (en) 2006-05-11 2010-02-23 Isis Pharmaceuticals, Inc. Bis-modified bicyclic nucleic acid analogs
DK2066684T3 (da) 2006-05-11 2012-10-22 Isis Pharmaceuticals Inc 5´-Modificerede bicycliske nukleinsyreanaloge
EP2439277B1 (en) 2006-05-30 2015-09-02 CropDesign N.V. Plants overexpressing SYR polypeptide having enhanced yield-related traits and a method for making the same
CA2651961A1 (en) 2006-05-31 2007-12-06 Metanomics Gmbh Manipulation of the nitrogen metabolism
BRPI0712304A2 (pt) 2006-06-08 2012-01-17 Basf Plant Science Gmbh método e processo para melhorar caracterìsticas de crescimento de planta em relação ás plantas de controle correspondentes, planta, parte de planta ou célula de planta, molécula de ácido nucleico isolada, construto de gene, vetor, planta transgênica, e, uso de uma molécula de ácido nucleico ou do construto de gene ou do vetor
EP2599870A3 (en) 2006-06-15 2013-09-11 CropDesign N.V. Plants having enhanced yield-related traits and a method for making the same
WO2007144190A2 (en) 2006-06-15 2007-12-21 Cropdesign N.V. Plants with modulated expression of nac transcription factors having enhanced yield-related traits and a method for making the same
WO2008002643A2 (en) 2006-06-28 2008-01-03 Cibus Llc Fatty acid blends and uses therefor
WO2008011473A2 (en) 2006-07-19 2008-01-24 Isis Pharmaceuticals, Inc. Compositions and their uses directed to hbxip
EP2189534B1 (en) 2006-08-02 2015-11-04 CropDesign N.V. Plants transformed with SYT-polypeptide having increased yield under abiotic stress and a method for making the same
CN104099368A (zh) 2006-08-02 2014-10-15 克罗普迪塞恩股份有限公司 具有改良特征的植物及其制备方法
DK2059600T3 (da) 2006-08-30 2014-07-07 Basf Plant Science Gmbh Fremgangsmåde til forøgelse af patogenresistensen i transgene planter
US8454948B2 (en) 2006-09-14 2013-06-04 Medgenics Medical Israel Ltd. Long lasting drug formulations
KR101470472B1 (ko) 2006-09-14 2014-12-09 메드제닉스 메디칼 이스라엘 리미티드 장기 지속형 약물 제형
ES2531391T3 (es) 2006-10-06 2015-03-13 Basf Plant Science Gmbh Delta-5 desaturasas y procedimiento para la preparación de ácidos grasos poliinsaturados en organismos transgénicos no humanos
AU2007306345B2 (en) 2006-10-12 2013-05-23 Basf Plant Science Gmbh Method for increasing pathogen resistance in transgenic plants
WO2008043849A2 (en) 2006-10-13 2008-04-17 Basf Plant Science Gmbh Plants with increased yield
EP2081954B1 (de) 2006-10-24 2012-06-13 BASF Plant Science GmbH Verfahren zur erhöhung der resistenz gegen biotrophe pilze in pflanzen
EP2082049A1 (en) 2006-11-16 2009-07-29 BASF Plant Science GmbH Plants having enhanced yield-related traits and a method for making the same using consensus sequences from the yabby protein family
BRPI0718977A2 (pt) 2006-11-24 2014-02-04 Cropdesign Nv Método para aumentar rendimento de sementes em plantas em relação às plantas de controle, construção, uso da mesma, planta, parte de planta ou célula de planta, método para a produção de uma planta transgênica tendo redimento aumentado de sementes em relação às plantas de controle, planta transgênica, partes colhíveis de uma planta, produtos, e, uso de um ácido nucleico
WO2008071767A1 (en) 2006-12-15 2008-06-19 Cropdesign N.V. Plants having enhanced seed yield-related traits and a method for making the same
EP2395093A3 (en) 2006-12-21 2012-08-01 BASF Plant Science GmbH Plants having enhanced yield-related traits and a method for making the same
EP1935428A1 (en) * 2006-12-22 2008-06-25 Antisense Pharma GmbH Oligonucleotide-polymer conjugates
EA023910B1 (ru) 2006-12-28 2016-07-29 Пайонир Хай-Бред Интернэшнл, Инк. Способ идентификации растения подсолнечника или зародышевой плазмы подсолнечника, имеющего устойчивость к orobanche
US9034815B2 (en) * 2007-01-10 2015-05-19 Moerae Matrix, Inc Polypeptide for treating or preventing adhesions
CA2898230C (en) * 2007-01-10 2018-04-24 Purdue Research Foundation Polypeptide inhibitors of hsp27 kinase and uses therefor
DK2202314T3 (da) 2007-01-15 2014-06-16 Basf Plant Science Gmbh Anvendelse af subtilisin (RNR9)-polynukleotider til opnåelse af patogenresistens i planter
AU2008209729B2 (en) 2007-01-30 2013-05-09 Cropdesign N.V. Plants having enhanced yield-related traits and a method for making the same
BRPI0807047A2 (pt) 2007-01-31 2014-04-22 Basf Plant Science Gmbh Método para o aumento da resistência ao estresse abiótico em plantas relativa as plantas de controle, e, usos de uma construção, e de um ácido nucleico que codifica um polipeptídeo semelhante a nap1.
WO2008098248A2 (en) 2007-02-09 2008-08-14 Northwestern University Particles for detecting intracellular targets
CA2679077A1 (en) 2007-02-28 2008-09-04 Cropdesign N.V. Plants having enhanced yield-related traits and a method for making the same
US8153863B2 (en) 2007-03-23 2012-04-10 New York University Transgenic plants expressing GLK1 and CCA1 having increased nitrogen assimilation capacity
CA2682349C (en) 2007-04-04 2017-08-22 Basf Plant Science Gmbh Ahas mutants
US9556210B2 (en) 2007-04-23 2017-01-31 Sabag-Rfa Ltd. System for delivering therapeutic agents into living cells and cells nuclei
PL2144633T3 (pl) * 2007-04-23 2015-02-27 Sabag Rfa Ltd Układ do transportu czynników terapeutycznych do żywych komórek i jąder komórkowych
US9156865B2 (en) 2007-04-23 2015-10-13 Deliversir Ltd System for delivering therapeutic agents into living cells and cells nuclei
AU2008248189A1 (en) 2007-05-03 2008-11-13 Basf Plant Science Gmbh Plants having enhanced yield-related traits and a method for making the same
US20100162432A1 (en) 2007-05-22 2010-06-24 Basf Plant Science Gmbh Plant cells and plants with increased tolerance and/or resistance to environmental stress and increased biomass production-ko
AR067318A1 (es) 2007-05-22 2009-10-07 Basf Plant Science Gmbh Plantas con mayor tolerancia y/o resistencia aumentada al estres ambiental y mayor produccion de biomasa
AU2008252852B2 (en) 2007-05-23 2014-08-07 Crop Functional Genomics Center Plants having enhanced yield-related traits and a method for making the same
WO2008145629A2 (en) 2007-05-25 2008-12-04 Cropdesign N.V. Yield enhancement in plants by modulation of maize alfins
EP2170917B1 (en) 2007-05-30 2012-06-27 Isis Pharmaceuticals, Inc. N-substituted-aminomethylene bridged bicyclic nucleic acid analogs
MX2009013046A (es) 2007-05-30 2010-02-17 Univ Northwestern Nanoparticulas con grupo funcional de acido nucleico para aplicaciones terapeuticas.
EP2173760B2 (en) 2007-06-08 2015-11-04 Isis Pharmaceuticals, Inc. Carbocyclic bicyclic nucleic acid analogs
DE112008001730T5 (de) 2007-06-29 2010-06-02 Basf Plant Science Gmbh Pflanzen mit verbesserten Ertragsmerkmalen und Verfahren zu ihrer Herstellung
CA2692579C (en) 2007-07-05 2016-05-03 Isis Pharmaceuticals, Inc. 6-disubstituted bicyclic nucleic acid analogs
CN101849009A (zh) 2007-07-20 2010-09-29 巴斯夫植物科学有限公司 具有增强的产率相关性状的植物及其制备方法
AR067766A1 (es) 2007-07-31 2009-10-21 Basf Plant Science Gmbh Metodo para modular la expresion de una planta de fosfoenolpiruvato carboxilasa (pepc), proteina de la caja u de clase iii y proteina de pqqc.
AR067748A1 (es) 2007-07-31 2009-10-21 Basf Plant Science Gmbh Plantas que tienen rasgos mejorados relacionados con el rendimiento y un metodo para obtenerlas
WO2009021137A2 (en) 2007-08-07 2009-02-12 Purdue Research Foundation Kinase inhibitors and uses thereof
JP5572090B2 (ja) 2007-08-15 2014-08-13 アイシス ファーマシューティカルズ， インコーポレーテッド テトラヒドロピラン核酸類似体
EP2205748A1 (en) 2007-09-14 2010-07-14 BASF Plant Science GmbH Plants having increased yield-related traits and a method for making the same
EP2193201A1 (en) 2007-09-18 2010-06-09 BASF Plant Science GmbH Plants with increased yield
WO2009039442A1 (en) 2007-09-21 2009-03-26 California Institute Of Technology Nfia in glial fate determination, glioma therapy and astrocytoma treatment
EP2594647A3 (en) 2007-09-21 2013-07-24 BASF Plant Science GmbH Plants with increased yield
EP2193203B1 (en) 2007-09-21 2012-07-25 BASF Plant Science GmbH Plants having increased yield-related traits and a method for making the same
WO2009045536A2 (en) * 2007-10-05 2009-04-09 The University Of North Carolina At Chapel Hill Receptor targeted oligonucleotides
PL2203565T3 (pl) * 2007-10-05 2016-02-29 Cibus Europe Bv Zmutowane geny syntazy kwasu acetohydroksy roślin kapustnych
US20110071047A1 (en) * 2007-10-27 2011-03-24 O.D. 260 Inc. Promoter detection and analysis
US20090111099A1 (en) * 2007-10-27 2009-04-30 Yongsheng Ma Promoter Detection and Analysis
CN102936605A (zh) 2007-10-29 2013-02-20 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物和用于制备该植物的方法
EP2220231B1 (en) 2007-11-12 2017-10-11 North Carolina State University Alteration of tobacco alkaloid content through modification of specific cytochrome p450 genes
EP2219680A2 (en) * 2007-11-13 2010-08-25 Isis Pharmaceuticals, Inc. Compounds and methods for modulating protein expression
US8916531B2 (en) 2007-11-20 2014-12-23 Isis Pharmaceuticals, Inc. Modulation of CD40 expression
MX2010005565A (es) 2007-11-20 2010-06-11 Pioneer Hi Bred Int Genes de señalizacion de etileno en maiz y su modulacion para mejor tolerancia al estres en plantas.
WO2009067647A1 (en) * 2007-11-21 2009-05-28 Isis Pharmaceuticals, Inc. Carbocyclic alpha-l-bicyclic nucleic acid analogs
BRPI0819286A2 (pt) 2007-11-22 2014-10-07 Cropdesign Nv Métodos para aumentar características relacionadas a rendimento em plantas em relação a plantas de controle e para a produção de plantas transgênicas, plantas, partes destas (incluindo sementes), ou células vegetais, construção, uso de uma construção, planta transgênica, partes aptas à colheita, produtos, e, uso de uma seqüência de ácidos nucléicos codificando um polipeptídeo amt.
AU2008328794B2 (en) 2007-11-26 2013-11-07 Basf Plant Science Gmbh Plants having enhanced yield-related traits and a method for making the same
DE112008003318T5 (de) 2007-12-19 2011-04-21 Basf Plant Science Gmbh Pflanzen mit erhöhtem Ertrag und erhöhter Toleranz gegenüber Umweltstress (IY-B)
US8575421B2 (en) 2007-12-20 2013-11-05 Basf Plant Science Gmbh Plants having enhanced yield-related traits and a method for making the same
DE112008003433T5 (de) 2007-12-21 2010-11-04 Basf Plant Science Gmbh Pflanzen mit erhöhtem Ertrag (KO NUE)
JP2011508047A (ja) * 2007-12-27 2011-03-10 サイバス，エルエルシー アルキルエステル脂肪酸配合物およびその用途
CN101965405B (zh) 2008-01-25 2014-03-05 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物和用于制备该植物的方法
WO2009095881A2 (en) 2008-01-31 2009-08-06 National Institute For Biological Sciences Plants having altered growth and/or development and a method for making the same
US8530640B2 (en) 2008-02-07 2013-09-10 Isis Pharmaceuticals, Inc. Bicyclic cyclohexitol nucleic acid analogs
DE112009000313T5 (de) 2008-02-27 2011-04-28 Basf Plant Science Gmbh Pflanzen mit erhöhtem Ertrag
WO2009117589A1 (en) 2008-03-21 2009-09-24 Isis Pharmaceuticals, Inc. Oligomeric compounds comprising tricyclic nucleosides and methods for their use
WO2009124238A1 (en) 2008-04-04 2009-10-08 Isis Pharmaceuticals, Inc. Oligomeric compounds comprising neutrally linked terminal bicyclic nucleosides
WO2009127671A1 (en) 2008-04-16 2009-10-22 Basf Plant Science Gmbh Plants having enhanced yield-related traits and a method for making the same
AR071624A1 (es) 2008-05-05 2010-06-30 Nat Inst For Biolog Sciences Plantas que tienen rasgos mejorados relacionados con el rendimiento y un metodo para obtenerlas mediante la expresion de un acido nucleico que codifica dna proteasa especifica de ubiquitina (ubp) de origen vegetal (ej. oryza)
JP2011520471A (ja) * 2008-05-23 2011-07-21 サイバス オイルズ，エルエルシー 酵母を使用したスクアレンの生成
BRPI0914777A2 (pt) 2008-06-20 2015-08-04 Basf Plant Science Gmbh Métodos para intensificar características relacionadas com o rendimento em plantas, e para a produção de uma planta transgênica, construto, uso de um construto, planta, parte de planta ou célula de planta, planta transgênica, partes colhíveis de uma planta, produtos, uso de um ácido nucleico, polipeptídeo isolado, e, ácido nucleico isolado.
CN102131934B (zh) 2008-06-26 2014-03-12 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物及其制备方法
AU2009265701A1 (en) 2008-07-04 2010-01-07 Basf Plant Science Gmbh Plants having enhanced yield-related traits and a method for making the same by overexpressing a polynucleotide encoding a TFL1-like protein
MX2011000483A (es) 2008-07-17 2011-02-24 Basf Plant Science Gmbh Plantas que tienen rasgos mejorados relacionados con el rendimiento y un metodo para producir las mismas.
CA2731038A1 (en) 2008-07-31 2010-02-04 Basf Plant Science Gmbh Plants having modified growth characteristics and a method for making the same
CA2735710A1 (en) 2008-08-04 2010-02-11 Glen N. Barber Sting (stimulator of interferon genes), a regulator of innate immune responses
BRPI0917855A2 (pt) 2008-08-19 2015-08-18 Basf Plant Science Gmbh Métodos para produzir uma célula de planta transgênica, planta ou parte da mesma, para produzir uma composição agrícola, para produzir uma planta transgênica, e para aumentar o rendimento, célula de planta transgênica, planta ou parte da mesma, semente, molécula de ácido nucleico isolada, construção de ácido nucleico, vetor, célula hospedeira, processos para produzir um polipeptídeo, e para identificar um composto, polipeptídeo, anticorpo, tecido de planta, material de propagação material colhido ou planta, composição, e, uso de uma proteína relacionada a rendimento ou proteína relacionada a estresse e a rendimento.
EP2315774A1 (en) 2008-08-20 2011-05-04 BASF Plant Science GmbH Plants having enhanced yield-related traits and a method for making the same
MX2011002143A (es) 2008-08-25 2011-07-20 Excaliard Pharmaceuticals Inc Oligonucleotidos antisentido dirigidos contra el factor de crecimiento del tejido conectivo y usos de los mismos.
CA2737303C (en) 2008-09-11 2019-06-11 Keygene N.V. Method for diagnostic marker development
WO2010034672A1 (en) 2008-09-23 2010-04-01 Basf Plant Science Gmbh Plants with increased yield (lt)
US8501805B2 (en) 2008-09-24 2013-08-06 Isis Pharmaceuticals, Inc. Substituted alpha-L-bicyclic nucleosides
DK2361256T3 (da) 2008-09-24 2013-07-01 Isis Pharmaceuticals Inc Cyclohexenyl-nukleinsyreanaloger
US9062322B2 (en) 2008-09-24 2015-06-23 Basf Plant Science Gmbh Plants having enhanced yield-related traits and a method for making the same
MX2011003266A (es) 2008-09-26 2011-07-20 Basf Agrochemical Products Bv Mutantes de acetohidroxiacido sintasa resistentes a herbicidas y metodos de uso.
NO2379084T3 (ja) 2008-10-15 2018-04-21
WO2010046422A2 (en) 2008-10-22 2010-04-29 Basf Se Use of auxin type herbicides on cultivated plants
WO2010046423A2 (en) 2008-10-22 2010-04-29 Basf Se Use of sulfonylurea herbicides on cultivated plants
MX2011004270A (es) 2008-10-23 2011-07-13 Basf Plant Science Gmbh Plantas con rendimiento aumentado (nue).
DE112009002342T5 (de) 2008-10-23 2012-06-14 Basf Plant Science Gmbh Verfahren zum Herstellen einer transgenen Zelle mit erhöhtem Gehalt an gamma-Aminobuttersäure (GABA)
EP2358398A2 (en) 2008-10-24 2011-08-24 Isis Pharmaceuticals, Inc. Oligomeric compounds and methods
CN102264374B (zh) 2008-10-24 2015-01-07 Isis制药公司 5′和2′双取代的核苷和由其制备的低聚化合物
EP2184351A1 (en) 2008-10-30 2010-05-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Polynucleotides encoding caryophyllene synthase and uses thereof
CN102197137A (zh) 2008-10-30 2011-09-21 先锋国际良种公司 对谷氨酰胺合成酶(gs)进行操作以改善高等植物中的氮利用效率和籽粒产量
MX2011004785A (es) 2008-11-12 2011-06-16 Basf Plant Science Gmbh Plantas que tienen mejor tolerancia al estres abiotico y/o mejores rasgos relacionados con el rendimiento y un metodo para producirlas.
BRPI0823236A2 (pt) 2008-11-14 2015-06-16 Fujian Fuda Biotech Co Ltd Fitase termotolerante de escherichia coli não-k12 e sua produção.
EP3335705A1 (en) 2008-11-24 2018-06-20 Northwestern University Polyvalent rna-nanoparticle compositions
EA201170752A1 (ru) 2008-12-03 2012-04-30 Басф Плант Сайенс Гмбх Растения с повышенной устойчивостью к абиотическому стрессу и/или улучшенными характеристиками урожайности и способ их получения
KR101829469B1 (ko) 2008-12-04 2018-03-30 큐알엔에이, 인크. Ｅｐｏ에 대한 천연 안티센스 전사체의 억제에 의해 에리트로포에틴(ｅｐｏ) 관련된 질환의 치료
KR101866152B1 (ko) 2008-12-04 2018-06-08 큐알엔에이, 인크. 종양 억제 유전자에 대한 천연 안티센스 전사체의 억제에 의해 종양 억제 유전자 관련된 질환의 치료
US8431775B2 (en) 2008-12-04 2013-04-30 Pioneer Hi Bred International Inc Methods and compositions for enhanced yield by targeted expression of knotted1
RU2551234C2 (ru) 2008-12-04 2015-05-20 КьюРНА,Инк.,US Лечение сиртуин 1 (sirt1)-связанных заболеваний путем ингибирования натурального антисмыслового транскрипта
BRPI0922448A2 (pt) 2008-12-10 2021-02-17 Purdue Research Foundation inibidor com base em peptídeo penetrante celular de quinases
DE112009003708T5 (de) 2008-12-12 2012-09-13 Basf Plant Science Gmbh Desaturasen und Verfahren zur Herstellung mehrfach ungesättigter Fettsäuren in transgenenOrganismen
DE112009003749T5 (de) 2008-12-17 2012-11-15 Basf Plant Science Gmbh Pflanzen mit gesteigerten ertragsbezogenen Eigenschaften und/oder gesteigerter abiotischerStresstoleranz und Verfahren zur Herstellung derselben
CA2746508A1 (en) 2008-12-17 2010-07-15 Avi Biopharma, Inc. Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis
EP2204086A1 (en) 2009-01-02 2010-07-07 Leibniz-Institut für Pflanzengenetik und Kulturpflanzenforschung (IPK) Six row-type barley
US20100233270A1 (en) 2009-01-08 2010-09-16 Northwestern University Delivery of Oligonucleotide-Functionalized Nanoparticles
CA2749163A1 (en) 2009-01-14 2010-07-22 The Salk Institute For Biological Studies Methods for screening and compounds that protect against amyloid diseases
EP2845903A3 (en) 2009-01-28 2015-06-10 BASF Plant Science Company GmbH Plants having enhanced yield-related traits and a method for making the same
US20120021515A1 (en) 2009-02-06 2012-01-26 Swayze Eric E Oligomeric compounds and methods
WO2010090969A1 (en) 2009-02-06 2010-08-12 Isis Pharmaceuticals, Inc. Tetrahydropyran nucleic acid analogs
CA2752237C (en) 2009-02-12 2020-03-24 Opko Curna, Llc Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf
WO2010093906A2 (en) 2009-02-12 2010-08-19 Curna, Inc. Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnf
CA2751323A1 (en) 2009-02-25 2010-09-02 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and a method for making the same
WO2010101818A1 (en) 2009-03-02 2010-09-10 Pioneer Hi-Bred International, Inc. Nac transcriptional activators involved in abiotic stress tolerance
WO2010102058A2 (en) 2009-03-04 2010-09-10 Curna, Inc. Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirt 1
US9464287B2 (en) 2009-03-16 2016-10-11 Curna, Inc. Treatment of nuclear factor (erythroid-derived 2)-like 2 (NRF2) related diseases by inhibition of natural antisense transcript to NRF2
WO2010107740A2 (en) 2009-03-17 2010-09-23 Curna, Inc. Treatment of delta-like 1 homolog (dlk1) related diseases by inhibition of natural antisense transcript to dlk1
EA201171245A1 (ru) 2009-04-14 2012-05-30 Пайонир Хай-Бред Интернешнл, Инк. Модуляция acc-синтазы, улучшающая урожайность растений при условиях низкого содержания азота
US20120047602A1 (en) 2009-04-21 2012-02-23 Basf Plant Science Company Gmbh RNA-Mediated Induction of Gene Expression in Plants
CA2759100A1 (en) 2009-04-21 2010-10-28 Basf Plant Science Company Gmbh Rna-mediated induction of gene expression in plants
EP3248618A1 (en) 2009-04-22 2017-11-29 Massachusetts Institute Of Technology Innate immune suppression enables repeated delivery of long rna molecules
EP2957637A3 (en) 2009-04-29 2016-03-23 BASF Plant Science Company GmbH Plants having enhanced yield-related traits and a method for making the same
CN104789573A (zh) 2009-04-29 2015-07-22 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物及其制备方法
NO2424987T3 (ja) 2009-05-01 2018-04-14
CN102439032B (zh) 2009-05-04 2015-07-22 先锋国际良种公司 通过调节ap2转录因子增加植物中的产量
US9155754B2 (en) 2009-05-06 2015-10-13 Curna, Inc. Treatment of ABCA1 gene related diseases by inhibition of a natural antisense transcript to ABCA1
MX2011011646A (es) 2009-05-06 2011-11-29 Basf Plant Science Co Gmbh Plantas que tienen mejores rasgos relacionados con el rendimiento y/o mejor tolerancia al estres abiotico y un metodo para producirlas.
KR101722541B1 (ko) 2009-05-06 2017-04-04 큐알엔에이, 인크. Ｔｔｐ에 대한 천연 안티센스 전사체의 억제에 의한 트리스테트라프롤린 관련된 질환의 치료
DK2432881T3 (en) 2009-05-18 2018-02-26 Curna Inc TREATMENT OF REPROGRAMMING FACTOR-RELATED DISEASES BY INHIBITING NATURAL ANTISENSE TRANSCRIPTS TO A REPROGRAMMING FACTOR
EP2432882B1 (en) 2009-05-22 2019-12-25 CuRNA, Inc. TREATMENT OF TRANSCRIPTION FACTOR E3 (TFE3) and INSULIN RECEPTOR SUBSTRATE 2 (IRS2) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO TFE3
WO2010138806A2 (en) 2009-05-28 2010-12-02 Curna, Inc. Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene
US20120171170A1 (en) 2009-06-16 2012-07-05 Opko Curna, Llc Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene
CN102612560B (zh) 2009-06-16 2017-10-17 库尔纳公司 通过抑制针对对氧磷酶1(pon1)的天然反义转录物来治疗pon1相关的疾病
BRPI1011353A2 (pt) 2009-06-19 2017-05-23 Basf Plant Science Co Gmbh métodos para intensificar as características relacionadas com o rendimento em plantas em relação às plantas de controle, e para produzir uma planta transgênica com rendimento aumentado, particularmente biomassa aumentada e/ou rendimento de sementes aumentado em relação às plantas de controle, planta ou parte da mesma ou célula vegetal, construto, usos de um construto e de um ácido nucleico, partes colhíveis de uma planta, produtos, molécula de ácido nucleico isolada, e, polipeptídeo isolado.
JP6073133B2 (ja) 2009-06-24 2017-02-01 クルナ・インコーポレーテッド 腫瘍壊死因子受容体２（ｔｎｆｒ２）に対する天然アンチセンス転写物の抑制によるｔｎｆｒ２関連疾患の治療
WO2010151674A2 (en) 2009-06-26 2010-12-29 Curna, Inc. Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
US20120174261A1 (en) 2009-06-30 2012-07-05 E. I. Du Pont De Nemours And Company Plant seeds with alterred storage compound levels, related constructs and methods involving genes encoding cytosolic pyrophosphatase
EP2272862B1 (en) 2009-07-10 2012-03-21 Freie Universität Berlin Rock2 and rock3, two new gain-of-function variants of the cytokinin receptors AHK2 and AHK3
EP2275564A1 (en) 2009-07-17 2011-01-19 Freie Universität Berlin Means and method for the production of transgenic plants that are resistant to clubroot
AU2010275363A1 (en) 2009-07-23 2012-02-02 Basf Plant Science Company Gmbh Plants with increased yield
US9175301B2 (en) 2009-07-24 2015-11-03 Pioneer Hi Bred International Inc Use of dimerization domain component stacks to modulate plant architecture
US9890195B2 (en) * 2009-07-27 2018-02-13 Purdue Research Foundation MK2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
US20110035843A1 (en) 2009-08-05 2011-02-10 Pioneer Hi-Bred International, Inc. Novel eto1 genes and use of same for reduced ethylene and improved stress tolerance in plants
ES2585360T3 (es) 2009-08-05 2016-10-05 Curna, Inc. Tratamiento de enfermedades relacionadas con un gen de la insulina (INS) por inhibición de la transcripción antisentido natural en un gen de la insulina (INS)
WO2011017521A2 (en) 2009-08-06 2011-02-10 Isis Pharmaceuticals, Inc. Bicyclic cyclohexose nucleic acid analogs
GB0914012D0 (en) 2009-08-11 2009-09-16 Plant Bioscience Ltd Stress tolerant plants
EP2949661A1 (en) 2009-08-19 2015-12-02 BASF Plant Science Company GmbH Plants having enhanced yield-related traits and a method for making the same
US20110061132A1 (en) 2009-08-20 2011-03-10 Pioneer Hi-Bred International, Inc. Functional expression of yeast nitrate transporter (ynt1) in maize to improve nitrate uptake
KR101892760B1 (ko) 2009-08-25 2018-08-28 큐알엔에이, 인크. ＩＱＧＡＰ에 대한 천연 안티센스 전사체의 억제에 의한 ＧＴＰａｓｅ 활성화 단백질을 함유하는 ＩＱ 모티프(ＩＱＧＡＰ)와 관련된 질환의 치료
EP3121283B1 (en) 2009-08-31 2018-05-02 BASF Plant Science Company GmbH Regulatory nucleic acid molecules for enhancing seed-specific gene expression in plants promoting enhanced polyunsaturated fatty acid synthesis
CN111560375A (zh) 2009-08-31 2020-08-21 巴斯夫植物科学有限公司 用于增强植物中种子特异的和/或种子优先的基因表达的调节性核酸分子
SG178389A1 (en) 2009-08-31 2012-03-29 Basf Plant Science Co Gmbh Regulatory nucleic acid molecules for enhancing constitutive gene expression in plants
EP2473522B1 (en) 2009-09-02 2016-08-17 Genentech, Inc. Mutant smoothened and methods of using the same
WO2011036160A1 (en) 2009-09-25 2011-03-31 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and a method for making the same
EP2480674A1 (en) 2009-09-25 2012-08-01 BASF Plant Science Company GmbH Plants having enhanced yield-related traits and a method for making the same
BR112012007516A2 (pt) 2009-10-02 2015-09-15 Pioneer Hi Bred Int ácido nucléico isolado, plantas , células vegetais, métodos de redução de produção de etileno em uma planta, de aumento de produtividade em uma planta e de aumento de tolerância à aridez, cassete de expressão e semente
WO2011048009A1 (en) 2009-10-22 2011-04-28 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and a method for making the same
BR112012009409A2 (pt) 2009-10-22 2017-02-21 Genentech Inc método de identificação de uma substância inibidora, molécula antagonista, ácido nucleico isolado, vetor, célula hospedeira, método para fabricar a molécula, composição, artigo de fabricação, método de inibição de uma atividade biológica, método de tratamento de uma condição patológica, método para detectar msp em uma amostra e método para detectar hepsina em uma amostra
WO2011053940A2 (en) 2009-10-30 2011-05-05 Northwestern University Templated nanoconjugates
AR078829A1 (es) 2009-10-30 2011-12-07 Du Pont Plantas y semillas con niveles alterados de compuesto de almacenamiento, construcciones relacionadas y metodos relacionados con genes que codifican proteinas similares a las aldolasas bacterianas de la clase ii del acido 2,4- dihidroxi-hept-2-eno-1,7-dioico
WO2011058029A1 (en) 2009-11-13 2011-05-19 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and a method for making the same
EP2499248B1 (en) 2009-11-13 2017-01-04 Sarepta Therapeutics, Inc. Antisense antiviral compound and method for treating influenza viral infection
MX2012005719A (es) 2009-11-17 2012-07-30 Basf Plant Science Co Gmbh Plantas con rendimiento aumentado.
ES2625154T3 (es) * 2009-11-23 2017-07-18 Nucelis Llc Métodos y composiciones para producir escualeno empleando levaduras
SG10201408598XA (en) 2009-11-30 2015-02-27 Genentech Inc Antibodies for treating and diagnosing tumors expressing slc34a2 (tat211 = seqid2 )
RU2639550C2 (ru) 2009-12-16 2017-12-21 Курна, Инк. Лечение заболеваний, связанных с сайт-1 мембраносвязанной пептидазой транскрипционных факторов (mbtps1), путем ингибирования природного антисмыслового транскрипта к mbtps1
WO2011079263A2 (en) 2009-12-23 2011-06-30 Curna, Inc. Treatment of uncoupling protein 2 (ucp2) related diseases by inhibition of natural antisense transcript to ucp2
WO2011079261A2 (en) 2009-12-23 2011-06-30 Curna, Inc. Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf
US8946514B2 (en) 2009-12-28 2015-02-03 E.I. Du Pont De Nemours And Company Sorghum fertility restorer genotypes and methods of marker-assisted selection
ES2657452T3 (es) 2009-12-29 2018-03-05 Curna, Inc. Tratamiento de enfermedades relacionadas con el factor respiratorio nuclear 1 (NRF1) mediante inhibición de transcrito antisentido natural a NRF1
WO2011090741A2 (en) 2009-12-29 2011-07-28 Opko Curna, Llc TREATMENT OF TUMOR PROTEIN 63 (p63) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO p63
WO2011082304A1 (en) 2009-12-31 2011-07-07 Pioneer Hi-Bred International, Inc. Engineering plant resistance to diseases caused by pathogens
WO2011082409A2 (en) 2010-01-04 2011-07-07 Curna, Inc. Treatment of interferon regulatory factor 8 (irf8) related diseases by inhibition of natural antisense transcript to irf8
KR101853509B1 (ko) 2010-01-06 2018-04-30 큐알엔에이, 인크. 췌장 발달 유전자에 대한 천연 안티센스 전사체의 억제에 의한 췌장 발달 유전자와 관련된 질환의 치료
MX2012007855A (es) 2010-01-06 2013-06-05 Du Pont Identificacion de ritmos diurnos en tejidos fotosinteticos del zea mays y uso en el mejoramiento de plantas de cultivo.
WO2011085102A1 (en) 2010-01-11 2011-07-14 Isis Pharmaceuticals, Inc. Base modified bicyclic nucleosides and oligomeric compounds prepared therefrom
ES2664866T3 (es) 2010-01-11 2018-04-23 Curna, Inc. Tratamiento de enfermedades relacionadas con la globulina fijadora de hormonas sexuales (shbg) mediante inhibición del transcrito antisentido natural a shbg
WO2011091244A1 (en) 2010-01-21 2011-07-28 NellOne Therapeutics, Inc. Methods to treat or prevent a skin condition using a nell1 peptide
WO2011091390A2 (en) 2010-01-25 2011-07-28 Opko Curna, Llc Treatment of rnase h1 related diseases by inhibition of natural antisense transcript to rnase h1
BR112012018618A2 (pt) 2010-01-26 2017-01-10 Pioneer Hi Bred Int método para seleção de uma planta ou germoplasma apresentando tolerãncia, tolerãncia aumentada, susceptibilidade, ou susceptibilidade aumentada a um ou mais herbicidas, planta, kit para seleção de pelo menos uma planta de soja, método de triagem de uma soja, método para controlar de modo seletivo plantas daninhas, método para triar de modo seletivo plantas de soja para tolerância a um ou mais herbicidas
US8962586B2 (en) 2010-02-22 2015-02-24 Curna, Inc. Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related diseases by inhibition of natural antisense transcript to PYCR1
MA34057B1 (fr) 2010-02-23 2013-03-05 Genentech Inc Compositions et methodes pour le diagnostic et le traitement d'une tumeur
WO2011105902A2 (en) 2010-02-23 2011-09-01 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Antagonists of complement component 8-beta (c8-beta) and uses thereof
WO2011105900A2 (en) 2010-02-23 2011-09-01 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Antagonists of complement component 8-alpha (c8-alpha) and uses thereof
WO2011105901A2 (en) 2010-02-23 2011-09-01 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Antagonists of complement component 9 (c9) and uses thereof
US9388423B2 (en) 2010-02-24 2016-07-12 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and a method for making the same
AU2011219927A1 (en) 2010-02-24 2012-08-23 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and a method for making the same
EP2361985A1 (en) 2010-02-26 2011-08-31 BASF Plant Science Company GmbH Plants having enhanced yield-related traits and a method for making the same
EP2361927A1 (en) 2010-02-26 2011-08-31 BASF Plant Science Company GmbH Plants having enhanced yield-related traits and a method for making the same
BR112012022045A8 (pt) 2010-03-03 2018-06-19 Du Pont ''planta transgênica,semente transgênica,método para produzir uma planta transgênica,método para produzir sementes transgênicas,produto e/ou subproduto,polinucleotídeo isolado e planta ou semente''.
GB201003702D0 (en) 2010-03-05 2010-04-21 Univ Warwick Molecular engineering of a floral inducer for crop improvement
WO2011112732A2 (en) 2010-03-12 2011-09-15 The Brigham And Women's Hospital, Inc. Methods of treating vascular inflammatory disorders
EP2545173A2 (en) 2010-03-12 2013-01-16 Sarepta Therapeutics, Inc. Antisense modulation of nuclear hormone receptors
WO2011115818A1 (en) 2010-03-17 2011-09-22 Isis Pharmaceuticals, Inc. 5'-substituted bicyclic nucleosides and oligomeric compounds prepared therefrom
WO2011114279A1 (en) 2010-03-18 2011-09-22 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and method for making the same
US20130036516A1 (en) 2010-03-18 2013-02-07 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and method for making the same
US20130019347A1 (en) 2010-03-19 2013-01-17 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and a method for making the same
CN102971427A (zh) 2010-03-19 2013-03-13 巴斯夫植物科学有限公司 具有增强的产量相关性状的植物和用于产生该植物的方法
EP2371845A1 (en) 2010-03-22 2011-10-05 BASF Plant Science Company GmbH Plants having enhanced yield-related traits and a method for making the same
JP5978203B2 (ja) 2010-04-09 2016-08-24 カッパーアールエヌエー，インコーポレイテッド Ｆｇｆ２１に対する天然アンチセンス転写物の阻害による線維芽細胞増殖因子（ｆｇｆ２１）線維芽細胞増殖因子ｆｇｆ２１）関連疾患の治療
EP2385129A1 (en) 2010-05-03 2011-11-09 BASF Plant Science Company GmbH Enhanced methods for gene regulation in plants
CN103118692A (zh) 2010-04-26 2013-05-22 Atyr医药公司 与半胱氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
JP6294074B2 (ja) 2010-04-27 2018-03-14 エータイアー ファーマ， インコーポレイテッド イソロイシルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
US9127033B2 (en) 2010-04-28 2015-09-08 Isis Pharmaceuticals, Inc. 5′ modified nucleosides and oligomeric compounds prepared therefrom
US8993723B2 (en) 2010-04-28 2015-03-31 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl-tRNA synthetases
JP6005628B2 (ja) 2010-04-28 2016-10-12 アイオーニス ファーマシューティカルズ， インコーポレーテッドＩｏｎｉｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． 修飾ヌクレオシド、その類似体、およびこれらから調製されるオリゴマー化合物
WO2011150279A2 (en) 2010-05-27 2011-12-01 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases
US8986680B2 (en) 2010-04-29 2015-03-24 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Asparaginyl tRNA synthetases
MX343559B (es) 2010-04-29 2016-11-10 Ionis Pharmaceuticals Inc Modulacion de la expresion de transtiretina.
CN103118693B (zh) 2010-04-29 2017-05-03 Atyr 医药公司 与缬氨酰‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
PE20130460A1 (es) 2010-05-03 2013-04-26 Genentech Inc Composiciones y metodos para el diagnostico y tratamiento de tumores
US8961961B2 (en) 2010-05-03 2015-02-24 a Tyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of arginyl-tRNA synthetases
AU2011248227B2 (en) 2010-05-03 2016-12-01 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases
EP2566496B1 (en) 2010-05-03 2018-02-28 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases
RU2018110642A (ru) 2010-05-03 2019-02-27 Курна, Инк. Лечение заболеваний, связанных с сиртуином (sirt), путем ингибирования природного антисмыслового транскрипта к сиртуину (sirt)
BR112012028132A2 (pt) 2010-05-04 2015-09-15 Basf Se plantas que tem tolerância aumentada a herbicidas
WO2011140267A2 (en) 2010-05-04 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex
WO2011139431A1 (en) 2010-05-06 2011-11-10 Pioneer Hi-Bred International, Inc. Maize acc synthase 3 gene and protein and uses thereof
GB201007834D0 (en) 2010-05-11 2010-06-23 Vib Vzw Growth promoting fusion proteins
ES2705236T3 (es) 2010-05-12 2019-03-22 Univ Columbia Procedimientos para producir células enteroendocrinas que producen y secretan insulina
CA3090304A1 (en) 2010-05-13 2011-11-17 Sarepta Therapeutics, Inc. Antisense modulation of interleukins 17 and 23 signaling
CN103200953B (zh) 2010-05-14 2017-02-15 Atyr 医药公司 与苯丙氨酰‑β‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
TWI531370B (zh) 2010-05-14 2016-05-01 可娜公司 藉由抑制ｐａｒ４天然反股轉錄本治療ｐａｒ４相關疾病
AU2011256366C1 (en) 2010-05-17 2017-06-15 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases
EP3299464B1 (en) 2010-05-26 2019-10-02 CuRNA, Inc. Treatment of atonal homolog 1 (atoh1) related diseases by inhibition of natural antisense transcript to atoh1
US8957200B2 (en) 2010-06-07 2015-02-17 Isis Pharmaceuticals, Inc. Bicyclic nucleosides and oligomeric compounds prepared therefrom
WO2011156202A1 (en) 2010-06-08 2011-12-15 Isis Pharmaceuticals, Inc. Substituted 2 '-amino and 2 '-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom
KR101591887B1 (ko) 2010-06-15 2016-02-04 메드제닉스 메디칼 이스라엘 리미티드 장기 지속형 약물 제형
DE112011102113T5 (de) 2010-06-24 2013-03-28 Basf Plant Science Company Gmbh Pflanzen mit gesteigerten Ertragsmerkmalen und Verfahren zu deren Herstellung
EP2585597A4 (en) 2010-06-25 2013-12-18 Basf Plant Science Co Gmbh PLANTS HAVING ENHANCED YIELD LINKS AND METHOD FOR OBTAINING SAME
CN103080320A (zh) 2010-07-01 2013-05-01 纳幕尔杜邦公司 涉及编码pae以及pae样多肽的基因并具有改变的贮藏化合物水平的植物种子、相关的构建体和的方法
WO2012004013A2 (en) 2010-07-08 2012-01-12 Bayer Bioscience N.V. Glucosinolate transporter protein and uses thereof
AU2011289831C1 (en) 2010-07-12 2017-06-15 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
CN103068982B (zh) 2010-07-14 2017-06-09 库尔纳公司 通过抑制盘状大同系物(dlg)的天然反义转录物而治疗dlg相关疾病
DE112011102378T5 (de) 2010-07-16 2013-04-18 Basf Plant Science Company Gmbh Pflanzen mit gesteigerten ertragsbezogenen Eigenschaften und Verfahren zur Herstellung derselben
UA112969C2 (uk) 2010-08-03 2016-11-25 Сібас Юс Ллс Рослина, стійка до одного або більше ррх-інгібуючих гербіцидів, яка містить мутантний ген протопорфіриноген ix оксидази (ррх)
US20120122223A1 (en) 2010-08-03 2012-05-17 Cibus Us Llc Mutated protoporphyrinogen ix oxidase (ppx) genes
US8993837B2 (en) 2010-08-13 2015-03-31 Pioneer Hi-Bred International, Inc Chimeric promoters and methods of use
US20140026257A1 (en) 2010-08-24 2014-01-23 Basf Plant Science Company Gmbh Plants Having Enhanced Yield-Related Traits and Method for Making the Same
WO2012027611A2 (en) 2010-08-25 2012-03-01 Atyr Pharma, Inc. INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF TYROSYL-tRNA SYNTHETASES
WO2012028673A1 (en) 2010-09-02 2012-03-08 Ludwig-Maximilians-Universitaet Muenchen Spontaneous organogenesis in plants
EP2426204A1 (en) 2010-09-02 2012-03-07 Ludwig-Maximilians-Universität München Spontaneous nodule organogenesis in plants
DK2625197T3 (en) 2010-10-05 2016-10-03 Genentech Inc Smoothened MUTANT AND METHODS OF USING THE SAME
EP2625274B1 (en) 2010-10-06 2017-07-19 CuRNA, Inc. Treatment of sialidase 4 (neu4) related diseases by inhibition of natural antisense transcript to neu4
CN103517990A (zh) 2010-10-07 2014-01-15 通用医疗公司 癌症生物标志物
JP6049623B2 (ja) 2010-10-22 2016-12-21 カッパーアールエヌエー，インコーポレイテッド α‐Ｌ‐イズロニダーゼ（ＩＤＵＡ）への天然アンチセンス転写物の阻害によるＩＤＵＡ関連疾患の治療
JP6073795B2 (ja) 2010-10-27 2017-02-01 カッパーアールエヌエー，インコーポレイテッド インターフェロン関連発生制御因子１（ｉｆｒｄ１）への天然アンチセンス転写物の阻害によるｉｆｒｄ１関連疾患の治療
BR112013011523A2 (pt) 2010-11-10 2019-09-24 Basf Plant Science Co Gmbh método, planta, construto, uso, planta transgênica, partes colhíveis de uma planta, produtos e partes colhíveis de uma planta
DK2638163T3 (en) 2010-11-12 2017-07-24 Massachusetts Gen Hospital POLYCOMB-ASSOCIATED NON-CODING RNAs
US8609621B2 (en) 2010-11-15 2013-12-17 E I Du Pont De Nemours And Company Acid-cleavable linkers exhibiting altered rates of acid hydrolysis
CA2817960C (en) 2010-11-17 2020-06-09 Isis Pharmaceuticals, Inc. Modulation of alpha synuclein expression
JP6071893B2 (ja) 2010-11-23 2017-02-01 カッパーアールエヌエー，インコーポレイテッド Ｎａｎｏｇへの天然アンチセンス転写物の阻害によるｎａｎｏｇ関連疾患の治療
EP2649180A4 (en) 2010-12-06 2014-05-21 Basf Plant Science Co Gmbh PROCESS FOR PRODUCING SYNTHETIC PROMOTERS WITH DEFINED SPECIFICITY
US11274313B2 (en) 2010-12-16 2022-03-15 BASF Agro B.V. Plants having increased tolerance to herbicides
AU2011349148C1 (en) 2010-12-22 2017-08-24 Pioneer Hi-Bred International, Inc. QTLs associated with and methods for identifying whole plant field resistance to Sclerotinia
WO2012097261A2 (en) 2011-01-14 2012-07-19 The General Hospital Corporation Methods targeting mir-128 for regulating cholesterol/lipid metabolism
BR112013018545A2 (pt) 2011-01-20 2019-02-05 Basf Plant Science Co Gmbh plantas com características melhoras relacionadas á produção e um método para produção das mesma
US9688719B2 (en) 2011-01-27 2017-06-27 Ramot At Tel-Aviv University Ltd. Glycogen synthase kinase-3 inhibitors
US9243034B2 (en) 2011-01-27 2016-01-26 Ramot At Tel-Aviv University Ltd. Glycogen synthase kinase-3 inhibitors
CN103796507B (zh) 2011-02-01 2017-09-01 科罗拉多小麦研究基金会公司 乙酰辅酶a羧化酶除草剂抗性植物
US20130338178A1 (en) 2011-02-02 2013-12-19 The Trustees Of Princeton University Sirtuin modulators as inhibitors of cytomegalovirus
MX365647B (es) 2011-02-02 2019-06-10 Excaliard Pharmaceuticals Inc El uso de compuestos antisentido dirigidos al factor de crecimiento del tejido conectivo (ctgf) para tratar queloides o cicatrices hipertroficas.
US9273336B2 (en) 2011-02-21 2016-03-01 E. I. Du Pont De Nemours And Company Recombinant host cells having an increase in buoyant density
AR085394A1 (es) 2011-02-25 2013-09-25 Univ Nac De La Plata Unlp Proteasa de plantas
EP2681323A4 (en) 2011-02-28 2015-03-18 Basf Plant Science Co Gmbh PLANTS WITH IMPROVED EFFICIENCY AND MANUFACTURING METHOD THEREFOR
MX2013009855A (es) 2011-02-28 2013-12-06 Basf Plant Science Co Gmbh Plantas que tienen rasgos relacionados con rendimiento mejorado y metodos para producir los mismos.
CA2827386A1 (en) 2011-03-01 2012-09-07 Basf Plant Science Company Gmbh Plants having enhanced yield-related traits and producing methods thereof
US9890200B2 (en) 2011-04-12 2018-02-13 Moerae Matrix, Inc. Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
JP6031510B2 (ja) 2011-04-12 2016-11-24 モイライ マトリックス インコーポレイテッド 異常な線維芽細胞増殖及び細胞外マトリックスの沈着を特徴とする疾患、症状又はプロセスを予防又は治療する組成物及び方法
WO2012148835A1 (en) 2011-04-29 2012-11-01 Pioneer Hi-Bred International, Inc. Down-regulation of a homeodomain-leucine zipper i-class homeobox gene for improved plant performance
WO2012156760A1 (en) 2011-05-19 2012-11-22 Consejo Superior De Investigaciones Cientificas Process for modifying the architecture and improving the yield of crop plants
WO2012170347A1 (en) 2011-06-09 2012-12-13 Isis Pharmaceuticals, Inc. Bicyclic nucleosides and oligomeric compounds prepared therefrom
ES2653247T3 (es) 2011-06-09 2018-02-06 Curna, Inc. Tratamiento de enfermedades relacionadas con la frataxina (FXN) mediante inhibición del transcrito antisentido natural al gen FXN
EP2721160A2 (en) 2011-06-14 2014-04-23 Synthon Biopharmaceuticals B.V. Compositions and methods for making and biocontaining auxotrophic transgenic plants
US20130097734A1 (en) 2011-07-12 2013-04-18 Two Blades Foundation Late blight resistance genes
CA2841782A1 (en) 2011-07-15 2013-01-24 Syngenta Participations Ag Methods of increasing yield and stress tolerance in a plant
WO2013012643A1 (en) 2011-07-15 2013-01-24 Syngenta Participations Ag Polynucleotides encoding trehalose-6-phosphate phosphatase and methods of use thereof
IN2014CN00793A (ja) 2011-08-01 2015-04-03 Basf Plant Science Co Gmbh
AU2012308302A1 (en) 2011-09-14 2014-03-20 Northwestern University Nanoconjugates able to cross the blood-brain barrier
AU2012308320C1 (en) 2011-09-14 2018-08-23 Translate Bio Ma, Inc. Multimeric oligonucleotide compounds
CN104011210B (zh) 2011-10-11 2018-05-01 布里格姆及妇女医院股份有限公司 神经退行性病症中的microRNA
CA2853449A1 (en) 2011-10-25 2013-05-02 Pioneer Hi-Bred International, Inc. Methods to alter plant cell wall composition for improved biofuel production and silage digestibility
MX2014005212A (es) 2011-10-31 2014-11-25 Pioneer Hi Bred Int Mejoramiento de la tolerancia a la sequia, eficiencia de uso de nitrogeno y rendimiento de una planta.
US10557136B2 (en) 2011-12-12 2020-02-11 Oncolmmunin Inc. In vivo delivery of oligonucleotides
CN104204192A (zh) 2012-02-13 2014-12-10 加米达细胞有限公司 间充质干细胞调理的基质及其产生和使用方法
US9452218B2 (en) 2012-03-09 2016-09-27 Purdue Research Foundation Compositions and methods for delivery of kinase inhibiting peptides
US9783814B2 (en) 2012-03-13 2017-10-10 Pioneer Hi-Bred International, Inc. Genetic reduction of male fertility in plants
WO2013138309A1 (en) 2012-03-13 2013-09-19 Pioneer Hi-Bred International, Inc. Genetic reduction of male fertility in plants
TR201815503T4 (tr) 2012-03-15 2018-11-21 Curna Inc Beyin kaynaklı nörotrofik faktör (bknf) ile ilişkili hastalıkların doğal antisens transkriptinin bknf'ye inhibisyonu ile muamelesi.
CA2907072A1 (en) 2012-03-16 2013-09-19 Valerion Therapeutics, Llc Antisense conjugates for decreasing expression of dmpk
WO2013154799A1 (en) 2012-04-09 2013-10-17 Isis Pharmaceuticals, Inc. Tricyclic nucleosides and oligomeric compounds prepared therefrom
US9221864B2 (en) 2012-04-09 2015-12-29 Isis Pharmaceuticals, Inc. Tricyclic nucleic acid analogs
CN104704122A (zh) 2012-04-20 2015-06-10 艾珀特玛治疗公司 产热的miRNA调节剂
EP3597741A1 (en) 2012-04-27 2020-01-22 Duke University Genetic correction of mutated genes
AU2013262663A1 (en) 2012-05-16 2015-01-22 The General Hospital Corporation D/B/A Massachusetts General Hospital Compositions and methods for modulating gene expression
KR20150030205A (ko) 2012-05-16 2015-03-19 라나 테라퓨틱스, 인크. Smn 유전자 패밀리 발현을 조절하기 위한 조성물 및 방법
US10045499B2 (en) 2012-05-24 2018-08-14 Iowa State University Research Foundation, Inc. Arabidopsis nonhost resistance gene(s) and use thereof to engineer disease resistant plants
WO2013184209A1 (en) 2012-06-04 2013-12-12 Ludwig Institute For Cancer Research Ltd. Mif for use in methods of treating subjects with a neurodegenerative disorder
AR091489A1 (es) 2012-06-19 2015-02-11 Basf Se Plantas que tienen una mayor tolerancia a herbicidas inhibidores de la protoporfirinogeno oxidasa (ppo)
EP2677035A1 (en) 2012-06-22 2013-12-25 BASF Plant Science Company GmbH Plants having enhanced yield-related traits and a method for making the same
US9567569B2 (en) 2012-07-23 2017-02-14 Gamida Cell Ltd. Methods of culturing and expanding mesenchymal stem cells
US9175266B2 (en) 2012-07-23 2015-11-03 Gamida Cell Ltd. Enhancement of natural killer (NK) cell proliferation and activity
CA2880833A1 (en) 2012-08-03 2014-02-06 Aptamir Therapeutics, Inc. Cell-specific delivery of mirna modulators for the treatment of obesity and related disorders
US9403865B2 (en) 2012-08-15 2016-08-02 Ionis Pharmaceuticals, Inc. Method of preparing oligomeric compounds using modified capping protocols
US10006041B2 (en) 2012-08-16 2018-06-26 Vib Vzw Means and methods for altering the lignin pathway in plants
WO2014037735A1 (en) 2012-09-10 2014-03-13 University Of Leicester Atsp1, an e3 ubiquitin ligase, and its use
US9029335B2 (en) 2012-10-16 2015-05-12 Isis Pharmaceuticals, Inc. Substituted 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom
AU2013336237A1 (en) 2012-10-22 2015-06-11 Sabag-Rfa Ltd A system for delivering therapeutic agents into living cells and cells nuclei
WO2014081673A2 (en) 2012-11-20 2014-05-30 Pioneer Hi-Bred International, Inc. Engineering plants for efficient uptake and utilization of urea to improve crop production
WO2014100525A2 (en) 2012-12-21 2014-06-26 Pioneer Hi-Bred International, Inc. Compositions and methods for auxin-analog conjugation
EP2754715A1 (en) 2013-01-11 2014-07-16 Consejo Superior De Investigaciones Científicas (CSIC) Stress tolerant plants
US10231397B2 (en) 2013-01-29 2019-03-19 Basf Plant Science Company Gmbh Fungal resistant plants expressing EIN2
US10435705B2 (en) 2013-01-29 2019-10-08 Basf Plant Science Company Gmbh Fungal resistant plants expressing HCP6
CA2897482A1 (en) 2013-01-29 2014-08-07 Basf Plant Science Company Gmbh Fungal resistant plants expressing hcp7
WO2014121436A1 (en) 2013-02-05 2014-08-14 Plant Bioscience Limited Transgenic plants
CN105008542B (zh) 2013-03-08 2020-02-07 巴斯夫植物科学有限公司 表达MybTF的抗真菌性植物
WO2014164014A1 (en) 2013-03-11 2014-10-09 Pioneer Hi-Bred International, Inc. Genes for improving nutrient uptake and abiotic stress tolerance in plants
US9803214B2 (en) 2013-03-12 2017-10-31 Pioneer Hi-Bred International, Inc. Breeding pair of wheat plants comprising an MS45 promoter inverted repeat that confers male sterility and a construct that restores fertility
RU2694686C2 (ru) 2013-03-12 2019-07-16 Е.И.Дюпон Де Немур Энд Компани Способы идентификации вариантных сайтов распознавания для редкощепящих сконструированных средств для индукции двунитевого разрыва, и композиции с ними, и их применения
WO2014164116A1 (en) 2013-03-13 2014-10-09 Pioneer Hi-Bred International, Inc. Functional expression of bacterial major facilitator superfamily (sfm) gene in maize to improve agronomic traits and grain yield
WO2014164074A1 (en) 2013-03-13 2014-10-09 Pioneer Hi-Bred International, Inc. Enhanced nitrate uptake and nitrate translocation by over-expressing maize functional low-affinity nitrate transporters in transgenic maize
CA2905128C (en) 2013-03-14 2023-01-03 Cibus Us Llc Mutated allene oxide synthase 2 (aos2) genes
CA2903693A1 (en) 2013-03-14 2014-10-02 Pioneer Hi-Bred International, Inc. Maize stress related transcription factor 18 and uses thereof
US9957515B2 (en) 2013-03-15 2018-05-01 Cibus Us Llc Methods and compositions for targeted gene modification
CN105143454A (zh) 2013-03-15 2015-12-09 先锋国际良种公司 Acc氧化酶多核苷酸和多肽的组合物和使用方法
CN105338805A (zh) 2013-03-15 2016-02-17 希博斯美国有限公司 采用寡核苷酸介导的基因修复提高靶向基因修饰的效率的方法和组合物
WO2014152507A2 (en) 2013-03-15 2014-09-25 Pioneer Hi-Bred International, Inc. Modulation of acc deaminase expression
KR102339732B1 (ko) * 2013-03-15 2021-12-15 시버스 유에스 엘엘씨 올리고뉴클레오타이드 매개 유전자 보수를 사용한 표적화된 유전자 변형의 효율을 증가시키기 위한 방법 및 조성물
AU2014234265B2 (en) 2013-03-21 2020-01-30 Universiteit Gent Means and methods for the reduction of photorespiration in crops
PT2992098T (pt) 2013-05-01 2019-07-05 Ionis Pharmaceuticals Inc Composições e métodos para modular a expressão de hbv e ttr
AU2014280847B2 (en) 2013-06-13 2019-07-04 Antisense Therapeutics Ltd Combination therapy
EP2816115A1 (en) 2013-06-17 2014-12-24 BASF Plant Science Company GmbH Plants having one or more enhanced yield-related traits and a method for making the same
WO2014207743A2 (en) 2013-06-24 2014-12-31 Ramot At Tel-Aviv University Ltd. Glycogen synthase kinase-3 inhibitors
US11459579B2 (en) 2013-07-09 2022-10-04 Board Of Trustees Of Michigan State University Transgenic plants produced with a K-domain, and methods and expression cassettes related thereto
WO2015006105A1 (en) 2013-07-09 2015-01-15 Board Of Trustees Of Michigan State University Transgenic plants produced with a k-domain, and methods and expression cassettes related thereto
US11162096B2 (en) 2013-10-14 2021-11-02 Ionis Pharmaceuticals, Inc Methods for modulating expression of C9ORF72 antisense transcript
CA2844640A1 (en) 2013-12-06 2015-06-06 The University Of British Columbia Method for treatment of castration-resistant prostate cancer
EP2896698A1 (en) 2014-01-17 2015-07-22 BASF Plant Science Company GmbH Plants having one or more enhanced yield-related traits and a method for making the same
WO2015116680A1 (en) 2014-01-30 2015-08-06 Two Blades Foundation Plants with enhanced resistance to phytophthora
US11236389B2 (en) 2014-01-31 2022-02-01 Temple University Of The Commonwealth System Of Higher Education BAG3 as a target for therapy of heart failure
WO2015120075A2 (en) 2014-02-04 2015-08-13 Genentech, Inc. Mutant smoothened and methods of using the same
CA2942407C (en) 2014-03-14 2023-09-26 Cibus Us Llc Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair
US10036019B2 (en) 2014-03-17 2018-07-31 Ionis Pharmaceuticals, Inc. Bicyclic carbocyclic nucleosides and oligomeric compounds prepared therefrom
US10006027B2 (en) 2014-03-19 2018-06-26 Ionis Pharmaceuticals, Inc. Methods for modulating Ataxin 2 expression
JP6902869B2 (ja) 2014-03-19 2021-07-14 アイオーニス ファーマシューティカルズ， インコーポレーテッドＩｏｎｉｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． アタキシン２の発現を調節するための組成物
DK3757214T3 (da) 2014-04-01 2022-07-04 Biogen Ma Inc Sammensætninger til modulering af sod-1-ekspression
WO2015150465A2 (en) 2014-04-03 2015-10-08 Basf Se Plants having increased tolerance to herbicides
US10221416B2 (en) 2014-04-24 2019-03-05 Ionis Pharmaceuticals, Inc. Oligomeric compounds comprising alpha-beta-constrained nucleic acid
PE20170010A1 (es) 2014-05-01 2017-03-04 Ionis Pharmaceuticals Inc Composiciones y metodos para modular la expresion del factor b del complemento
WO2015171603A1 (en) 2014-05-06 2015-11-12 Two Blades Foundation Methods for producing plants with enhanced resistance to oomycete pathogens
ES2725948T3 (es) 2014-06-04 2019-09-30 Exicure Inc Suministro multivalente de inmunomoduladores mediante ácidos nucleicos esféricos liposomales para aplicaciones profilácticas o terapéuticas
EP4039807A1 (en) 2014-06-10 2022-08-10 Erasmus University Rotterdam Medical Center Antisense oligonucleotides useful in treatment of pompe disease
EP3760208B1 (en) 2014-06-25 2024-05-29 The General Hospital Corporation Targeting human satellite ii (hsatii)
CA2985344A1 (en) 2014-06-26 2015-12-30 The Trustees Of Columbia University In The City Of New York Inhibition of serotonin expression in gut enteroendocrine cells results in conversion to insulin-positive cells
EP3166964A1 (en) 2014-07-08 2017-05-17 Vib Vzw Means and methods to increase plant yield
ES2965286T3 (es) 2014-07-14 2024-04-12 Univ Washington State Silenciamiento de NANOS que abate las células germinales
WO2016033424A1 (en) 2014-08-29 2016-03-03 Genzyme Corporation Methods for the prevention and treatment of major adverse cardiovascular events using compounds that modulate apolipoprotein b
WO2016040748A1 (en) 2014-09-12 2016-03-17 Ionis Pharmaceuticals, Inc. Compositions and methods for detection of smn protein in a subject and treatment of a subject
EP3663403A1 (en) 2014-09-26 2020-06-10 University of Massachusetts Rna-modulating agents
JP6702957B2 (ja) 2014-10-06 2020-06-03 アルトリア クライアント サービシーズ リミテッド ライアビリティ カンパニー タバコ植物における腋芽成長の遺伝的制御法
JP2018501201A (ja) 2014-11-17 2018-01-18 モイライ マトリックス インコーポレイテッド 異常な線維芽細胞増殖および細胞外マトリックス沈着を特徴とする疾患、状態、またはプロセスを予防または処置するための組成物および方法
CN107106493A (zh) 2014-11-21 2017-08-29 西北大学 球形核酸纳米颗粒缀合物的序列特异性细胞摄取
CA2971425A1 (en) 2014-12-16 2016-06-23 Pioneer Hi-Bred International, Inc. Restoration of male fertility in wheat
US9688707B2 (en) 2014-12-30 2017-06-27 Ionis Pharmaceuticals, Inc. Bicyclic morpholino compounds and oligomeric compounds prepared therefrom
WO2016112132A1 (en) 2015-01-06 2016-07-14 Ionis Pharmaceuticals, Inc. Compositions for modulating expression of c9orf72 antisense transcript
WO2016115490A1 (en) 2015-01-16 2016-07-21 Ionis Pharmaceuticals, Inc. Compounds and methods for modulation of dux4
CA2972881A1 (en) 2015-01-21 2016-07-28 Basf Se Plants having increased tolerance to herbicides
WO2016124918A1 (en) 2015-02-03 2016-08-11 The Institute Of Genetics And Developmental Biology Plants with increased seed size
US10485196B2 (en) 2015-02-03 2019-11-26 The Institute Of Genetics And Developmental Biology Chinese Academy Of Scinces Rice plants with altered seed phenotype and quality
WO2016124515A1 (en) 2015-02-04 2016-08-11 Basf Plant Science Company Gmbh Method of increasing resistance against soybean rust in transgenic plants by increasing the scopoletin content
GB201501941D0 (en) 2015-02-05 2015-03-25 British American Tobacco Co Method
US10676726B2 (en) 2015-02-09 2020-06-09 Duke University Compositions and methods for epigenome editing
BR112017016789A2 (pt) 2015-02-11 2018-05-08 Basf Se métodos para produzir uma planta transgênica, para controlar a vegetação indesejada e para o cultivo da planta, molécula de ácido nucleico, construção de ácido nucleico, vetor, polipeptídeo hppd mutado, núcleo de célula vegetal, núcleo de célula vegetal transgênica, planta transgênica, uso do ácido nucleico, combinação útil, processo para a preparação de uma combinação útil e uso de uma combinação útil
GB201502409D0 (en) 2015-02-13 2015-04-01 British American Tobacco Co Method
US11129844B2 (en) 2015-03-03 2021-09-28 Ionis Pharmaceuticals, Inc. Compositions and methods for modulating MECP2 expression
KR20170125090A (ko) 2015-03-12 2017-11-13 모레 매트릭스 인코포레이티드 비-세포 폐암을 치료하기 위한 mk2 저해제 펩타이드-함유 조성물의 용도
MY186899A (en) 2015-03-18 2021-08-26 Basf Se Recombinant microorganism for improved production of fine chemicals
US10961532B2 (en) 2015-04-07 2021-03-30 The General Hospital Corporation Methods for reactivating genes on the inactive X chromosome
US10407678B2 (en) 2015-04-16 2019-09-10 Ionis Pharmaceuticals, Inc. Compositions for modulating expression of C9ORF72 antisense transcript
WO2016182881A1 (en) 2015-05-09 2016-11-17 Two Blades Foundation Late blight resistance gene from solanum americanum and methods of use
EP3303372A2 (en) 2015-06-04 2018-04-11 Basf Se Recombinant microorganism for improved production of fine chemicals
MX2017016109A (es) 2015-06-12 2018-04-20 Basf Se Microorganismo recombinante para la produccion mejorada de productos quimicos finos.
US20180161429A1 (en) 2015-06-26 2018-06-14 Beth Israel Deaconess Medical Center Inc. Cancer therapy targeting tetraspanin 33 (tspan33) in myeloid derived suppressor cells
CA2991045A1 (en) 2015-06-29 2017-01-05 Caris Science, Inc. Therapeutic oligonucleotides binding c1q
EP3328873A4 (en) 2015-07-28 2019-04-10 Caris Science, Inc. TARGETED OLIGONUCLEOTIDES
PT3353303T (pt) 2015-09-25 2023-10-10 Academisch Ziekenhuis Leiden Composições e métodos para modulação da expressão de ataxina 3
WO2017062790A1 (en) 2015-10-09 2017-04-13 Two Blades Foundation Cold shock protein receptors and methods of use
EP4089175A1 (en) 2015-10-13 2022-11-16 Duke University Genome engineering with type i crispr systems in eukaryotic cells
AR106931A1 (es) 2015-10-22 2018-03-07 Basf Se Plantas que tienen una mayor tolerancia a herbicidas
CA3007424A1 (en) 2015-11-05 2017-05-11 Children's Hospital Los Angeles "mobilizing leukemia cells"
EP3377086B1 (en) 2015-11-19 2024-05-01 The Brigham and Women's Hospital, Inc. Lymphocyte antigen cd5-like (cd5l)-interleukin 12b (p40) heterodimers in immunity
US11058709B1 (en) 2015-12-04 2021-07-13 Ionis Pharmaceuticals, Inc. Methods of treating breast cancer
EP3387127A1 (en) 2015-12-07 2018-10-17 Erasmus University Medical Center Rotterdam Enzymatic replacement therapy and antisense therapy for pompe disease
EP3400300A4 (en) 2016-01-05 2019-08-07 Ionis Pharmaceuticals, Inc. METHODS FOR REDUCING LRRK2 EXPRESSION
CA3019952A1 (en) 2016-02-04 2017-08-10 Curis, Inc. Mutant smoothened and methods of using the same
WO2017138986A1 (en) 2016-02-09 2017-08-17 Cibus Us Llc Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair
CA3054284A1 (en) 2016-02-25 2017-08-31 The Brigham And Women's Hospital, Inc. Treatment methods for fibrosis targeting smoc2
JP7015243B2 (ja) 2016-03-11 2022-02-02 アルトリア クライアント サーヴィシーズ リミテッド ライアビリティ カンパニー 吸枝が減少又は消失したタバコ植物及びタバコ製品を生産する組成物及び方法
US10577607B2 (en) 2016-03-16 2020-03-03 Ionis Pharmaceuticals, Inc. Modulation of DYRK1B expression
WO2017161172A1 (en) 2016-03-16 2017-09-21 Ionis Pharmaceuticals, Inc. Methods of modulating keap1
CA3018066A1 (en) 2016-03-18 2017-09-21 Caris Science, Inc. Oligonucleotide probes and uses thereof
US11913054B2 (en) 2016-03-30 2024-02-27 Basf Se Fermentative production of n-butylacrylate using alcohol acyl transferase enzymes
US10563216B2 (en) 2016-04-18 2020-02-18 Bloomsburg University of Pennsylvania Compositions and methods of delivering molecules to plants
EP4166661A1 (en) 2016-04-29 2023-04-19 BASF Plant Science Company GmbH Fused donor - guide nucleic acid and methods for modification of target nucleic acids
EP3054014A3 (en) 2016-05-10 2016-11-23 BASF Plant Science Company GmbH Use of a fungicide on transgenic plants
MX2018014245A (es) 2016-05-20 2019-03-28 Basf Agro Bv Peptidos de transito dual para el direccionamiento a polipeptidos.
BR112018072479B1 (pt) 2016-05-24 2023-01-31 Basf Se Método para controlar o crescimento de ervas daninhas, uso do composto de fórmula (i) e uso da composição
AU2017271579B2 (en) 2016-05-25 2023-10-19 Caris Science, Inc. Oligonucleotide probes and uses thereof
MX2018014496A (es) 2016-05-26 2019-03-28 Nunhems Bv Plantas productoras de frutas sin semillas.
WO2017219017A1 (en) 2016-06-17 2017-12-21 Ionis Pharmaceuticals, Inc. Modulation of gys1 expression
BR112018076811A2 (pt) 2016-06-22 2019-08-27 Univ North Carolina State métodos, usos, construção ou vetor, célula, planta, material de propagação de planta, folha colhida, folha processada, produto de planta, produto de tabaco, extrato de planta e artigo de fumar
US11253601B2 (en) 2016-07-11 2022-02-22 Translate Bio Ma, Inc. Nucleic acid conjugates and uses thereof
CN109688807B (zh) 2016-07-15 2023-04-28 巴斯夫欧洲公司 具有增加的除草剂耐受性的植物
CN109790153A (zh) 2016-07-27 2019-05-21 巴斯夫农业公司 具有增加的除草剂耐受性的植物
WO2018019845A1 (en) 2016-07-29 2018-02-01 Basf Se Method for controlling ppo resistant weeds
CA3030354A1 (en) 2016-07-29 2018-02-01 Basf Se Method for controlling ppo resistant weeds
WO2018024696A1 (en) 2016-08-05 2018-02-08 Basf Se Method for controlling ppo resistant weeds
WO2018024695A1 (en) 2016-08-05 2018-02-08 Basf Se Method for controlling ppo resistant weeds
NL2017294B1 (en) 2016-08-05 2018-02-14 Univ Erasmus Med Ct Rotterdam Natural cryptic exon removal by pairs of antisense oligonucleotides.
NL2017295B1 (en) 2016-08-05 2018-02-14 Univ Erasmus Med Ct Rotterdam Antisense oligomeric compound for Pompe disease
EP3278667A1 (en) 2016-08-05 2018-02-07 Basf Se Method for controlling ppo-inhibitor resistant weeds
BR112019001862B1 (pt) 2016-08-09 2022-10-18 Basf Se Métodos para controlar o crescimento de ervas daninhas resistentes a ppo, e uso do composto de fórmula (i).1
US10905121B2 (en) 2016-08-09 2021-02-02 Basf Se Method for controlling PPO resistant weeds
US11193136B2 (en) 2016-08-09 2021-12-07 Vib Vzw Cellulose synthase inhibitors and mutant plants
EP3281523A1 (en) 2016-08-09 2018-02-14 Basf Se Method for controlling ppo resistant weeds
EP3281524A1 (en) 2016-08-09 2018-02-14 Basf Se Method for controlling ppo resistant weeds
US20190166841A1 (en) 2016-08-09 2019-06-06 Basf Se Method for Controlling PPO Resistant Weeds
EP3281525A1 (en) 2016-08-09 2018-02-14 Basf Se Method for controlling ppo resistant weeds
KR20190065341A (ko) 2016-10-06 2019-06-11 아이오니스 파마수티컬즈, 인코포레이티드 올리고머 화합물들의 접합 방법
US10647989B2 (en) 2016-10-07 2020-05-12 Altria Client Services Llc Composition and methods for producing tobacco plants and products having reduced tobacco-specific nitrosamines (TSNAs)
EP3532638A4 (en) 2016-10-31 2020-07-29 University of Massachusetts TARGETING MICROARN-101-3 P IN CARCINOTHERAPY
JOP20190104A1 (ar) 2016-11-10 2019-05-07 Ionis Pharmaceuticals Inc مركبات وطرق لتقليل التعبير عن atxn3
WO2018102745A1 (en) 2016-12-02 2018-06-07 Cold Spring Harbor Laboratory Modulation of lnc05 expression
CN110462047A (zh) 2016-12-16 2019-11-15 双刃基金会 晚疫病抗性基因及使用方法
CA3044728A1 (en) 2016-12-20 2018-06-28 BASF Agro B.V. Plants having increased tolerance to herbicides
CA3048521A1 (en) 2016-12-27 2018-07-05 Inbiose N.V. In vivo synthesis of sialylated compounds
WO2018140214A1 (en) 2017-01-24 2018-08-02 Pioneer Hi-Bred International, Inc. Nematicidal protein from pseudomonas
US20190367937A1 (en) 2017-02-09 2019-12-05 Fujian Agriculture And Forestry University Expression of a phosphate transporter for improving plant yield
WO2018165564A1 (en) 2017-03-09 2018-09-13 Ionis Pharmaceuticals, Inc. Morpholino modified oligomeric compounds
JP2020517638A (ja) 2017-04-20 2020-06-18 エータイアー ファーマ， インコーポレイテッド 肺の炎症を治療するための組成物および方法
WO2018195486A1 (en) 2017-04-21 2018-10-25 The Broad Institute, Inc. Targeted delivery to beta cells
US11445692B2 (en) 2017-05-15 2022-09-20 Equi-Nom Ltd. Quantitative trait loci (QTL) associated with shatter resistant capsules in sesame and uses thereof
EP3658675A1 (en) 2017-07-28 2020-06-03 Two Blades Foundation Potyvirus resistance genes and methods of use
AU2018318231A1 (en) 2017-08-18 2020-02-13 Ionis Pharmaceuticals, Inc. Modulation of the notch signaling pathway for treatment of respiratory disorders
WO2019051173A1 (en) 2017-09-08 2019-03-14 Ionis Pharmaceuticals, Inc. MODULATORS OF SMAD7 EXPRESSION
US11104912B2 (en) 2017-09-11 2021-08-31 Altria Client Services Llc Compositions and methods for producing tobacco plants and products having reduced or eliminated suckers
WO2019055460A1 (en) 2017-09-13 2019-03-21 The Children's Medical Center Corporation COMPOSITIONS AND METHODS FOR THE TREATMENT OF TRANSPOSON-ASSOCIATED DISEASES
TWI809004B (zh) 2017-11-09 2023-07-21 美商Ionis製藥公司 用於降低snca表現之化合物及方法
WO2019108619A1 (en) 2017-11-28 2019-06-06 Two Blades Foundation Methods and compositions for enhancing the disease resistance of plants
EP3716765A4 (en) 2017-11-29 2021-08-25 Basf Se PLANTS WITH INCREASED TOLERANCE TO HERBICIDES
WO2019125804A1 (en) 2017-12-20 2019-06-27 Basf Se Nucleases and methods for making and using them
WO2019126641A2 (en) 2017-12-21 2019-06-27 Ionis Pharmaceuticals, Inc. Modulation of frataxin expression
US11034969B2 (en) 2017-12-22 2021-06-15 Altria Client Services Llc Plant comprising recombinant polynucleotides encoding a pigment regulatory transcription factor with a tissue-preferred promoter
CN107868123B (zh) 2017-12-25 2020-05-12 中国农业科学院作物科学研究所 一种同时提高植物产量和抗性的基因及其应用
CA3087266A1 (en) 2018-01-09 2019-07-18 Cibus Us Llc Shatterproof genes and mutations
US11732271B2 (en) 2018-01-12 2023-08-22 The Sainsbury Laboratory Stem rust resistance genes and methods of use
AU2019206731A1 (en) 2018-01-15 2020-07-30 Ionis Pharmaceuticals, Inc. Modulators of DNM2 expression
WO2019142099A1 (en) 2018-01-17 2019-07-25 Basf Se Plants having increased tolerance to herbicides
BR112020014242A2 (pt) 2018-02-14 2020-12-15 Institute Of Genetics And Developmental Biology, Chinese Academy Of Sciences Métodos de aumento da eficiência de uso de nutriente
PE20210109A1 (es) 2018-03-02 2021-01-19 Ionis Pharmaceuticals Inc Moduladores de la expresion de irf4
WO2019169243A1 (en) 2018-03-02 2019-09-06 Ionis Pharmaceuticals, Inc. Compounds and methods for the modulation of amyloid-beta precursor protein
WO2019183440A1 (en) 2018-03-22 2019-09-26 Ionis Pharmaceuticals, Inc. Methods for modulating fmr1 expression
WO2019186514A2 (en) 2018-03-30 2019-10-03 Rheinische Friedrich-Wilhelms-Universitat Bonn Aptamers for targeted activaton of t cell-mediated immunity
US11377665B2 (en) 2018-04-03 2022-07-05 Altria Client Services Llc Composition and methods for producing tobacco plants and products having increased phenylalanine and reduced tobacco-specific nitrosamines (TSNAs)
CA3096274A1 (en) 2018-04-06 2019-10-10 Children's Medical Center Corporation Compositions and methods for somatic cell reprogramming and modulating imprinting
MX2020010721A (es) 2018-04-11 2020-11-06 Ionis Pharmaceuticals Inc Moduladores de la expresion de ezh2.
EP3784779A1 (en) 2018-04-26 2021-03-03 Basf Se Lipase enzymes
US20210115422A1 (en) 2018-05-03 2021-04-22 Basf Se Amylase enzymes
US20210355497A1 (en) 2018-05-09 2021-11-18 Ionis Pharmaceuticals, Inc. Compounds and methods for reducing fxi expression
EA202092500A1 (ru) 2018-05-09 2021-03-01 Ионис Фармасьютикалз, Инк. Соединения и способы для снижения экспрессии atxn3
WO2019219933A1 (en) 2018-05-17 2019-11-21 Vib Vzw An engineered combinatorial module of transcription factors to boost production of monoterpenoid indole alkaloids
EP3807411A4 (en) 2018-06-14 2022-08-03 Ionis Pharmaceuticals, Inc. COMPOUNDS AND METHODS FOR ENHANCING STMN2 EXPRESSION
EP3806619A1 (en) 2018-06-15 2021-04-21 Nunhems B.V. Seedless watermelon plants comprising modifications in an abc transporter gene
TWI833770B (zh) 2018-06-27 2024-03-01 美商Ionis製藥公司 用於減少 lrrk2 表現之化合物及方法
CN112805004A (zh) 2018-07-02 2021-05-14 艾珀特玛治疗公司 向人脂肪细胞靶向递送治疗剂
CA3106986A1 (en) 2018-07-25 2020-01-30 Ionis Pharmaceuticals, Inc. Compounds and methods for reducing atxn2 expression
CA3110661A1 (en) 2018-08-29 2020-03-05 University Of Massachusetts Inhibition of protein kinases to treat friedreich ataxia
AU2019334672A1 (en) 2018-09-07 2021-03-25 Basf Plant Science Company Gmbh Improved method for the production of high levels of PUFA in plants
CA3110651A1 (en) 2018-09-07 2020-03-12 Basf Plant Science Company Gmbh Improved method for the production of high levels of pufa in plants
US20220025391A1 (en) 2018-09-07 2022-01-27 Basf Plant Science Company Gmbh Improved method for the production of high levels of pufa in plants
CA3116477A1 (en) 2018-10-18 2020-04-23 Basf Se Method for the production of acrylic acid or salts thereof
TW202028222A (zh) 2018-11-14 2020-08-01 美商Ionis製藥公司 Foxp3表現之調節劑
US11208650B2 (en) 2018-11-15 2021-12-28 Ionis Pharmaceuticals, Inc. Modulators of IRF5 expression
CA3124395A1 (en) 2018-12-20 2020-06-25 Basf Plant Science Company Gmbh Native delivery of biomolecules into plant cells using ionic complexes with cell-penetrating peptides
US20220017931A1 (en) 2019-01-22 2022-01-20 Basf Se Method for production of 4-cyano benzoic acid or salts thereof
US20200239899A1 (en) 2019-01-24 2020-07-30 Altria Client Services Llc Tobacco Plants Comprising Reduced Nicotine and Reduced Tobacco Specific Nitrosamines
SG11202107399WA (en) 2019-01-31 2021-08-30 Ionis Pharmaceuticals Inc Modulators of yap1 expression
GB201902253D0 (en) 2019-02-19 2019-04-03 Univ Court Univ Of Glasgow Methods for optogenetic manipulation of stomatal function
WO2020171889A1 (en) 2019-02-19 2020-08-27 University Of Rochester Blocking lipid accumulation or inflammation in thyroid eye disease
CA3131700A1 (en) 2019-02-27 2020-09-03 Ionis Pharmaceuticals, Inc. Modulators of malat1 expression
WO2020185737A1 (en) 2019-03-11 2020-09-17 Basf Se Amylases and methods for making and using them
CA3133614A1 (en) 2019-03-14 2020-09-17 Rothamsted Research Limited Genetically modified plants with enhanced drought tolerance
WO2020193532A1 (en) 2019-03-25 2020-10-01 Basf Se Cleaning composition having amylase enzymes
US20220162576A1 (en) 2019-03-25 2022-05-26 Basf Se Amylase enzymes
US20220170001A1 (en) 2019-03-25 2022-06-02 Basf Se Amylase Enzymes
MX2021011916A (es) 2019-03-29 2021-10-26 Ionis Pharmaceuticals Inc Compuestos y metodos para modular ube3a-ats.
EP3966334A1 (en) 2019-05-10 2022-03-16 Basf Se Regulatory nucleic acid molecules for enhancing gene expression in plants
BR112021026248A2 (pt) 2019-06-27 2022-03-03 Two Blades Found Molécula de ácido nucleico isolada que codifica uma proteína atrlp23 engenheirada, proteína atrlp23 engenheirada, cassete de expressão, vetor, célula hospedeira, planta ou célula vegetal, métodos para fazer uma proteína atrlp23 engenheirada, para fazer uma molécula de ácido nucleico que codifica uma proteína atrlp23 engenheirada e para intensificar a resistência de uma planta
CA3143570A1 (en) 2019-06-27 2020-12-30 Basf Plant Science Company Gmbh Methods for transformation of fungal spores
WO2021011348A1 (en) 2019-07-12 2021-01-21 The Regents Of The University Of California Plants with enhanced resistance to bacterial pathogens
EP3956450A4 (en) 2019-07-26 2022-11-16 Ionis Pharmaceuticals, Inc. COMPOUNDS AND METHODS FOR MODULATION OF GFAP
JP2022544587A (ja) 2019-08-15 2022-10-19 アイオーニス ファーマシューティカルズ， インコーポレーテッド 結合修飾オリゴマー化合物及びその使用
JP2022545465A (ja) 2019-08-22 2022-10-27 ビーエーエスエフ ソシエタス・ヨーロピア アミラーゼバリアント
AU2020344905A1 (en) 2019-09-12 2022-04-28 Basf Se Regulatory nucleic acid molecules for enhancing gene expression in plants
WO2021058691A1 (en) 2019-09-26 2021-04-01 Basf Se Method for the production of beta-alanine or salts thereof
WO2021069387A1 (en) 2019-10-07 2021-04-15 Basf Se Regulatory nucleic acid molecules for enhancing gene expression in plants
US20230148071A1 (en) 2019-12-03 2023-05-11 Basf Se Regulatory nucleic acid molecules for enhancing gene expression in plants
EP4077682A1 (en) 2019-12-16 2022-10-26 BASF Agricultural Solutions Seed US LLC Improved genome editing using paired nickases
WO2021121921A1 (en) 2019-12-16 2021-06-24 BASF Agricultural Solutions Seed US LLC Codon-optimized cas9 endonuclease encoding polynucleotide
US20230220405A1 (en) 2019-12-16 2023-07-13 BASF Agricultural Solutions Seed US LLC Precise introduction of dna or mutations into the genome of wheat
US20220064638A1 (en) 2020-02-28 2022-03-03 Ionis Pharmaceuticals, Inc. Compounds and methods for modulating smn2
EP4114954A1 (en) 2020-03-04 2023-01-11 Basf Se Method for the production of constitutive bacterial promoters conferring low to medium expression
CN115176018A (zh) 2020-03-04 2022-10-11 巴斯夫欧洲公司 用于大肠杆菌和芽孢杆菌中表达的穿梭载体
CA3181546A1 (en) 2020-05-01 2021-11-04 Ionis Pharmaceuticals, Inc. Compounds and methods for modulating atxn1
EP4150064A1 (en) 2020-05-15 2023-03-22 Basf Se Improved method for the production of isoprenoids
MX2022016338A (es) 2020-06-29 2023-01-24 Ionis Pharmaceuticals Inc Compuestos y metodos para modular la plp1.
US11730133B2 (en) 2020-10-21 2023-08-22 Equi-Nom Ltd High yield sesame
KR20230108728A (ko) 2020-11-18 2023-07-18 아이오니스 파마수티컬즈, 인코포레이티드 앤지오텐시노겐 발현을 조절하기 위한 화합물 및 방법
AU2021401424A1 (en) 2020-12-18 2023-06-29 Ionis Pharmaceuticals, Inc. Compounds and methods for modulating factor xii
WO2022240931A1 (en) 2021-05-11 2022-11-17 Two Blades Foundation Methods for preparing a library of plant disease resistance genes for functional testing for disease resistance
BR112023026050A2 (pt) 2021-06-18 2024-03-05 Ionis Pharmaceuticals Inc Compostos e métodos para reduzir expressão de ifnar1
CN118019447A (zh) 2021-08-06 2024-05-10 Kws蔬菜有限责任公司 菠菜对霜霉病的持久抗性
CA3230261A1 (en) 2021-09-03 2023-03-09 Manuel Dubald Plants having increased tolerance to herbicides
US11395470B1 (en) 2021-09-14 2022-07-26 Equi-Nom Ltd. Sesame with high oil content and/or high yield
WO2023043220A1 (ko) 2021-09-16 2023-03-23 주식회사 큐마인 Wfdc2의 발현을 조절하는 안티센스 화합물
AU2022356378A1 (en) 2021-09-30 2024-05-02 Two Blades Foundation Plant disease resistance genes against stem rust and methods of use
WO2023067192A1 (en) 2021-10-21 2023-04-27 Consejo Superior De Investigaciones Cientificas (Csic) Methods for improving abiotic stress resistance
WO2023105244A1 (en) 2021-12-10 2023-06-15 Pig Improvement Company Uk Limited Editing tmprss2/4 for disease resistance in livestock
AU2022422286A1 (en) 2021-12-22 2024-07-04 BASF Agricultural Solutions Seed US LLC Improved screening method for genome edited events
WO2023131616A1 (en) 2022-01-05 2023-07-13 Vib Vzw Means and methods to increase abiotic stress tolerance in plants
WO2023131637A1 (en) 2022-01-06 2023-07-13 Vib Vzw Improved silage grasses
WO2023144199A1 (en) 2022-01-26 2023-08-03 Vib Vzw Plants having reduced levels of bitter taste metabolites
WO2024026474A1 (en) 2022-07-29 2024-02-01 Regeneron Pharmaceuticals, Inc. Compositions and methods for transferrin receptor (tfr)-mediated delivery to the brain and muscle
WO2024044352A1 (en) 2022-08-26 2024-02-29 The General Hospital Corporation Methods and compositions for prognosis and treatment of dilated cardiomyopathy and heart failure
WO2024083579A1 (en) 2022-10-20 2024-04-25 Basf Se Regulatory nucleic acid molecules for enhancing gene expression in plants
WO2024089011A1 (en) 2022-10-26 2024-05-02 BASF Agricultural Solutions Seed US LLC Excision of recombinant dna from the genome of plant cells
WO2024094678A2 (en) 2022-11-02 2024-05-10 Basf Se Improved method for the production of natural vanillin
US20240182561A1 (en) 2022-11-04 2024-06-06 Regeneron Pharmaceuticals, Inc. Calcium voltage-gated channel auxiliary subunit gamma 1 (cacng1) binding proteins and cacng1-mediated delivery to skeletal muscle
US20240173426A1 (en) 2022-11-14 2024-05-30 Regeneron Pharmaceuticals, Inc. Compositions and methods for fibroblast growth factor receptor 3-mediated delivery to astrocytes
WO2024126113A1 (en) 2022-12-12 2024-06-20 BASF Agricultural Solutions Seed US LLC Plants having increased tolerance to herbicides
WO2024132947A1 (en) 2022-12-19 2024-06-27 Basf Se New cellulase promoters for fungal protein production

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4503151A (en) * 1980-12-10 1985-03-05 Research Corporation Recombinant cDNA construction method and hybrid nucleotides useful in cloning
US4873191A (en) * 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4882279A (en) * 1985-10-25 1989-11-21 Phillips Petroleum Company Site selective genomic modification of yeast of the genus pichia
DE3788914T2 (de) * 1986-09-08 1994-08-25 Ajinomoto Kk Verbindungen zur Spaltung von RNS an eine spezifische Position, Oligomere, verwendet bei der Herstellung dieser Verbindungen und Ausgangsprodukte für die Synthese dieser Oligomere.
US4950599A (en) * 1987-01-29 1990-08-21 Wolf Bertling Method for exchanging homologous DNA sequences in a cell using polyoma encapsulated DNA fragments
WO1990014092A1 (en) * 1989-05-18 1990-11-29 Cell Genesys, Inc. Single-strand site-directed modification of mammalian genes in vivo
ATE244763T1 (de) * 1992-02-11 2003-07-15 Cell Genesys Inc Erzielen von homozygotem durch zielgerichtete genetische ereignisse
AU4115693A (en) * 1992-04-24 1993-11-29 Sri International In vivo homologous sequence targeting in eukaryotic cells
WO1994004032A1 (en) * 1992-08-21 1994-03-03 The Regents Of The University Of California Composition and method for altering dna sequences by homologous recombination
AU6527094A (en) * 1993-03-31 1994-10-24 Hybridon, Inc. Modified oligonucleotides having improved anti-influenza activity

Also Published As

Publication number Publication date
NZ278490A (en) 1998-03-25
KR960706500A (ko) 1996-12-09
CN1048254C (zh) 2000-01-12
PT733059E (pt) 2001-03-30
AU1399595A (en) 1995-06-27
US5565350A (en) 1996-10-15
US5756325A (en) 1998-05-26
WO1995015972A1 (en) 1995-06-15
CN1215755A (zh) 1999-05-05
DE69425903T2 (de) 2001-02-15
EP0733059A4 (en) 1997-05-21
EP0733059A1 (en) 1996-09-25
US5871984A (en) 1999-02-16
GR3034988T3 (en) 2001-03-30
EP0733059B1 (en) 2000-09-13
AU691550B2 (en) 1998-05-21
CA2178729A1 (en) 1995-06-15
KR100386337B1 (ko) 2004-03-24
DE69425903D1 (de) 2000-10-19
CN1117866C (zh) 2003-08-13
ATE196311T1 (de) 2000-09-15
DK0733059T3 (da) 2000-10-16
DE733059T1 (de) 1997-08-28
CN1142829A (zh) 1997-02-12
JPH09506511A (ja) 1997-06-30
ES2149962T3 (es) 2000-11-16

Similar Documents

Publication Publication Date Title
JP3585238B2 (ja) 真核細胞における部位特異的突然変異誘発のための化合物および方法
US7053195B1 (en) Locked nucleic acid containing heteropolymers and related methods
CN110770342B (zh) Dna被编辑了的真核细胞的制造方法、和在该方法中使用的试剂盒
JP3832851B2 (ja) 人工トランスポゾンのｉｎｖｉｔｒｏにおける転位
AU740702B2 (en) Cell-free chimeraplasty and eukaryotic use of heteroduplex mutational vectors
AU2004284374B2 (en) DNA cloning vector plasmids and methods for their use
CA2258090A1 (en) Chimeric mutational vectors having non-natural nucleotides
JP7078946B2 (ja) ゲノム編集方法
WO2018030208A1 (ja) 遺伝子ノックイン細胞の作製方法
US20030148352A1 (en) Intracellular generation of single-stranded DNA
JP5947309B2 (ja) オリゴヌクレオチドを用いたｄｎａの標的改変
EP1533375B1 (en) Method of transferring mutation into target nucleic acid
JP2024006091A (ja) ｔｒａｃｒＲＮＡユニット、及びゲノム編集方法
KR20050021366A (ko) 표적 핵산내 돌연변이 도입 방법

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040316

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040531

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20040720

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20040803

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080813

Year of fee payment: 4

LAPS Cancellation because of no payment of annual fees